A Roadmap for Human Liver Differentiation from Pluripotent Stem Cells
Open accessAbstract
How are closely related lineages, including liver, pancreas, and intestines, diversified from a common endodermal origin? Here, we apply principles learned from developmental biology to rapidly reconstitute liver progenitors from human pluripotent stem cells (hPSCs). Mapping the formation of multiple endodermal lineages revealed how alternate endodermal fates (e.g., pancreas and intestines) are restricted during liver commitment. Human liver fate was encoded by combinations of inductive and repressive extracellular signals at different doses. However, these signaling combinations were temporally re-interpreted: cellular competence to respond to retinoid, WNT, TGF-β, and other signals sharply changed within 24 hr. Consequently, temporally dynamic manipulation of extracellular signals was imperative to suppress the production of unwanted cell fates across six consecutive developmental junctures. This efficiently generated 94.1% ± 7.35% TBX3 + HNF4A + human liver bud progenitors and 81.5% ± 3.2% FAH + hepatocyte-like cells by days 6 and 18 of hPSC differentiation, respectively; the latter improved short-term survival in the Fah −/− Rag2 −/− Il2rg −/− mouse model of liver failure.
AI snapshot
Written from the paper’s full text.
TL;DR
This paper maps human liver differentiation from pluripotent stem cells as six consecutive lineage choices, showing that extracellular signals are temporally re-interpreted within 24 hr to specify liver while suppressing pancreas, intestine, and biliary fates. The resulting protocol rapidly generates liver bud progenitors and hepatocyte-like cells that engraft and improve short-term survival in FRG mice.
Key findings
- Temporally dynamic manipulation of RA, WNT, TGF-β, BMP, FGF, and PKA signals across six developmental junctures generated 94.1% ± 7.35% TBX3+ HNF4A+ human liver bud progenitors by day 6 and 81.5% ± 3.2% FAH+ hepatocyte-like cells by day 18 of hPSC differentiation.
- Day-6 liver bud progenitors were identified by a CD99hiCD10−CD184lo/− surface profile, and an FAH-2A-Clover knockin hESC reporter tracked FAH expression in hepatocyte-like cells.
- Day-18 hPSC-derived hepatocytes secreted ALBUMIN (5.89 ± 0.71 μg/mL) and FIBRINOGEN (1.38 ± 0.26 μg/mL), had CYP3A4 activity 5.9-fold higher than HepG2 cells but 55-fold lower than primary adult human hepatocytes, and stained positive for periodic acid Schiff and ASGR1.
- In FRG mice, hPSC-derived hepatocytes engrafted in 7 of 15 neonatal mice; in adult intrasplenic transplants, 72.7% survived longer than negative controls, with human ALBUMIN at 120 ± 36 ng/mL versus 2.06 μg/mL for primary human hepatocytes, and reduced serum bilirubin.
Methods
- hPSCs (H1, H7, H9, ESI035, and others) were differentiated through anterior primitive streak and definitive endoderm, then posterior foregut, liver bud progenitors, and hepatocyte-like cells using sequential extracellular signal manipulations; purity was assessed by flow cytometry and marker expression.
- The study screened 242 cell-surface antigens across day-0 hPSCs, day-2 definitive endoderm, and day-6 liver bud progenitors; used CRISPR/Cas9 to generate a FAH-2A-Clover reporter; and performed microarray profiling (GEO: GSE98324).
- In vivo testing used neonatal intrahepatic and adult intrasplenic transplantation into FRG mice with cyclical NTBC withdrawal, with bioluminescence, human ALBUMIN, and bilirubin measurements.
Limitations
- The paper states that the bipotent capacity of liver bud progenitors to give rise to hepatic or biliary fates remains to be formally demonstrated in vivo by single-cell lineage tracing.
- The paper states that hPSC-derived hepatocytes are less metabolically functional than primary human hepatocytes, with CYP3A4 activity 55-fold lower and mouse bloodstream human ALBUMIN ~18-fold lower than adult human hepatocytes; the FRG mouse benefit was short-term survival.
- Evident from the text: in vivo validation is limited to immunodeficient FRG mouse models and short-term outcomes, so long-term maturation, durability, and safety of the hPSC-derived cells are not established.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
7 of 19 cited sources checked · 6 supported · 0 flagged · accuracy not yet measured
- Premisecitation
HNF4A+ liver progenitors were typically formed on later days (by day 10-14) in other differentiation protocols.
“whereas HNF4A+ liver progenitors were typically formed on later days (by day 10–14) in other differentiation protocols (Carpentier et al., 2016; Hay et al., 2008; Si-Tayeb et al., 2010; Zhao et al., 2013).”
Quote in the paperSubstantial claim2 of 3 sources checked - Interpretationown data
RA is crucial for human posterior foregut specification.
“Thus, RA is crucial for human posterior foregut specification, consistent with the role for RA in generating foregut derivatives such as stomach endoderm in vitro (McCracken et al., 2014) and how inhibiting RA synthesis abrogates both liver and pancreas formation in zebrafish embryos (Stafford and Prince, 2002).”
Quote in the paperSubstantial claim1 of 2 sources checked - Interpretationcitation
These lineage segregations could be efficiently negotiated by providing the relevant inductive signal(s) to drive differentiation toward the desired lineage while repressing the signal(s) that otherwise promoted the alternate fate.
“With this knowledge, these lineage segregations could be efficiently negotiated by providing the relevant inductive signal(s) to drive differentiation toward the desired lineage while repressing the signal(s) that otherwise promoted the alternate fate (Loh et al., 2014).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Loh et al., 2014 source
- Interpretationcitation
The amounts of ALBUMIN and FIBRINOGEN secreted by day-18 hPSC-derived hepatocytes were in the same order of magnitude as the amount secreted by hepatocytes in vivo in human beings.
“Second, day-18 hPSC-derived hepatocytes secreted ALBUMIN and FIBRINOGEN proteins into the medium (5.89 ± 0.71 μg/mL and 1.38 ± 0.26 μg/mL, respectively [Figures 4G and S4L]) in the same order of magnitude as the amount secreted by hepatocytes in vivo in human beings (Bernardi et al., 2012; Tennent et al., 2007).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites Bernardi et al., 2012 source
The Introduction (page not specified) gives an in-vivo human albumin production rate of 9–12 g per day and says liver cells release albumin into the bloodstream. It gives no fibrinogen secretion rate and does not establish that either in-vivo rate is in the same order of magnitude as the reported day-18 culture-medium concentrations. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Tennent et al., 2007 source
- Findingown data
PKA agonists (e.g., 8-bromo-cAMP) potently specified liver bud from foregut.
“Second, we found that PKA agonists (e.g., 8-bromo-cAMP) also potently specified liver bud from foregut (Figure 2F), supporting the notion that prostaglandin E2 specifies zebrafish liver progenitors by activating the PKA cascade (Nissim et al., 2014).”
Quote in the paperSubstantial claim
- Findingown data
hPSC-derived liver bud progenitors did not express CDX or HOX genes, which are markers of the midgut/hindgut.
“Reciprocally, hPSC-derived liver bud progenitors did not express CDX or HOX genes (Figures 2I and S2A), which are markers of the midgut/hindgut, a developmentally related lineage that emanates from adjacent posterior endoderm and is also specified by BMP and FGF signals (Sherwood et al., 2011; Spence et al., 2011b).”
Quote in the paperSubstantial claim - Findingown data
Treatment of day-2 endoderm with the RA agonists ATRA (2 μM) or TTNPB (75 nM) for 24 hr enhanced the formation of day-3 posterior foregut that was later competent to differentiate into liver bud and downstream hepatocytes.
“Treatment of day-2 endoderm with the RA agonists all-trans RA (ATRA; 2 μM) or 4-[(E)-2-(5,6, 7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl] benzoic acid (TTNPB) (75 nM) for24 hr enhanced the formation of day-3 posterior foregut that was later competent to differentiate into liver bud (Figures 1F–1H) and downstream hepatocytes (Figures S1A and S1B) on later days of differentiation.”
Quote in the paperSubstantial claim - Findingown data
TGF-β inhibition at days 4-6 abrogated the differentiation of foregut into liver bud.
“Emphasizing the importance of TGF-β activation, we found that TGF-β inhibition at this stage abrogated the differentiation of foregut into liver bud (Figure 2D), contrasting with earlier use of TGF-β inhibitors to differentiate hPSC-derived endoderm into liver (Loh et al., 2014; Sampaziotis et al., 2015; Touboul et al., 2010).”
Quote in the paperSubstantial claim - Findingown data
Day-3 BMP inhibition reduced the competence of hPSC-derived foregut progenitors to later differentiate into liver bud progenitors.
“Unexpectedly, although BMP inhibition expanded the foregut domain in Xenopus and zebrafish (Rankin et al., 2011; Tiso et al., 2002), conversely, day-3 BMP inhibition reduced the competence of hPSC-derived foregut progenitors to later differentiate into liver bud progenitors (Figure 1J).”
Quote in the paperSubstantial claim - Findingown data
Day-2 definitive endoderm could be converted into day-3 posterior foregut by simultaneous activation of RA, BMP, and FGF pathways together with inhibition of TGF-β signaling for 24 hr.
“Taken together, day-2 definitive endoderm could be converted into day-3 posterior foregut by the simultaneous activation of RA, BMP, and FGF pathways together with inhibition of TGF-β signaling for 24 hr.”
Quote in the paperSubstantial claim - Findingown data
Day-6 liver bud progenitors expressed liver bud transcription factors HNF4A, TBX3, HNF6, and CEBPA, which were low or undetectable in midgut/hindgut.
“Day-6 liver bud progenitors expressed liver bud transcription factors HNF4A, TBX3, HNF6, and CEBPA, which were low or undetectable in midgut/hindgut (Figures 2C – 2F and S2A).”
Quote in the paperSubstantial claim - Findingown data
The approach rapidly generated 85.8%, 92%, and 89.2% pure AFP+ liver bud progenitor populations by day 6 of differentiation from the H1, H7, and H9 hPSC lines, respectively.
“This approach rapidly generated an 85.8%, a 92%, and an 89.2% pure AFP+ liver bud progenitor population by day 6 of differentiation from the H1, H7, and H9 hPSC lines, respectively (Figures 2G and 2H).”
Quote in the paperSubstantial claim - Findingown data
Liver bud specification on days 4-6 required activation of the TGF-β, BMP, and PKA pathways, together with WNT inhibition, for 48-72 hr.
“Instead, liver bud specification on days 4–6 required activation of the TGF-β, BMP, and protein kinase A (PKA) pathways, together with WNT inhibition, for 48–72 hr (Figure 2B).”
Quote in the paperSubstantial claim - Findingown data
Transient activation of the RA, BMP, and FGF pathways together with inhibition of TGF-β signaling for 24 hr was critical to differentiate day-2 definitive endoderm into day-3 posterior foregut that was competent to later differentiate into liver bud progenitors.
“First, we determined that transient activation of the retinoic acid (RA), BMP, and FGF pathways together with inhibition of TGF-β signaling for 24 hr was critical to differentiate day-2 definitive endoderm into day-3 posterior foregut that was competent to later differentiate into liver bud progenitors.”
Quote in the paperSubstantial claim - Findingown data
Cellular competence to respond to retinoid, WNT, TGF-β, and other signals sharply changed within 24 hr during hPSC differentiation.
“However, these signaling combinations were temporally re-interpreted: cellular competence to respond to retinoid, WNT, TGF-β, and other signals sharply changed within 24 hr.”
Quote in the paperSubstantial claim - Findingown data
Human liver fate is encoded by combinations of inductive and repressive extracellular signals at different doses.
“Human liver fate was encoded by combinations of inductive and repressive extracellular signals at different doses.”
Quote in the paperSubstantial claim - Findingown data
Continued RA activation and TGF-β inhibition suppressed the subsequent differentiation of day-3 posterior foregut into day-6 liver bud progenitors.
“Although day-3 posterior foregut was initially specified by RA activation and TGF-β inhibition, the subsequent differentiation of posterior foregut into day-6 liver bud progenitors was suppressed by continued RA activation and TGF-β inhibition.”
Quote in the paperSubstantial claim - Findingown data
The differentiation protocol generated 81.5% ± 3.2% FAH+ hepatocyte-like cells by day 18 of hPSC differentiation.
“This efficiently generated 94.1% ± 7.35% TBX3+ HNF4A+ human liver bud progenitors and 81.5% ± 3.2% FAH+ hepatocyte-like cells by days 6 and 18 of hPSC differentiation, respectively”
- Also stated in: § Segregation of Human Liver Bud Progenitors into Hepatocyte versus Biliary Fates by Competing NOTCH, TGF-β, PKA, and Other Signals · plain
“Applying the aforementioned differentiation protocol to FAH-2A-Clover hESCs revealed that 81.5 ± 3.2% of day-18 hepatocyte-like cells were FAH-Clover+ (Figure 5E).”
Quote in the paperSubstantial claim - Also stated in: § Segregation of Human Liver Bud Progenitors into Hepatocyte versus Biliary Fates by Competing NOTCH, TGF-β, PKA, and Other Signals · plain
- Findingcitation
Day-3 hPSC-derived posterior foregut expressed HHEX, a marker of ∼E8.5 mouse ventral posterior foregut.
“Such day-3 hPSC-derived posterior foregut expressed HHEX (Figure S1H), a marker of ∼E8.5 mouse ventral posterior foregut (Thomas et al., 1998).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Thomas et al., 1998 source
- Findingown data
Dorsal (MNX1), stomach (ODD1), and pancreatic (PDX1) endoderm markers were low or undetectable in hPSC-derived liver bud progenitors in comparison to hPSC-derived pancreatic endoderm or midgut/hindgut.
“Dorsal (MNX1), stomach (ODD1), and pancreatic (PDX1) endoderm markers were low or undetectable in hPSC-derived liver bud progenitors in comparison to hPSC-derived pancreatic endoderm or midgut/hindgut (Figure 2I).”
Quote in the paperSubstantial claim - Findingown data
The differentiation protocol generated 94.1% ± 7.35% HNF4A+ (or TBX3+ HNF4A+) human liver bud progenitors by day 6 of hPSC differentiation.
“This efficiently generated 94.1% ± 7.35% TBX3+ HNF4A+ human liver bud progenitors and 81.5% ± 3.2% FAH+ hepatocyte-like cells by days 6 and 18 of hPSC differentiation, respectively”
- Also stated in: § TGF-β, BMP, and PKA Activation and WNT Inhibition Induce Differentiation of Foregut into Liver Bud Progenitors by Day 6 of Differentiation · plain
“By day 6 of hPSC differentiation, 94.1% ± 7.35% HNF4A+ pure liver bud progenitors were produced (Figure S3A)”
Quote in the paperSubstantial claim - Also stated in: § TGF-β, BMP, and PKA Activation and WNT Inhibition Induce Differentiation of Foregut into Liver Bud Progenitors by Day 6 of Differentiation · plain
- Findingown data
PKA agonists (e.g., 8-bromo-cAMP and forskolin) also had a similar effect on expression of tyrosine metabolic pathway genes and liver markers.
“PKA agonists (e.g., 8-bromo-cAMP and forskolin) also had a similar effect (Figure S4D).”
Quote in the paperSubstantial claim - Findingown data
Inhibition of NOTCH and TGF-β consolidated hepatocyte commitment by inhibiting diversion into the SOX9+ biliary fate.
“Conversely, inhibition of NOTCH and TGF-β consolidated hepatocyte commitment by inhibiting diversion into the SOX9+ biliary fate (Figures 4C and 4D).”
Quote in the paperSubstantial claim - Findingnone given
An FAH-Clover knockin reporter hESC line tracks the subsequent generation of FAH+ hepatocyte-like cells.
“Third, we also introduce tools to track the process of liver commitment: (1) the surface marker CD99, which, together with the absence of CD10 and CD184/CXCR4, identifies day-6 liver bud progenitors and (2) an FAH-Clover knockin reporter hESC line to track the subsequent generation of FAH+ hepatocyte-like cells.”
Quote in the paperSubstantial claim - Findingown data
Bilirubin levels were reduced in the serum of mice transplanted with hPSC-derived or primary human hepatocytes.
“Finally, bilirubin levels (reflecting the extent of liver injury) were reduced in the serum of mice transplanted with hPSC-derived or primary human hepatocytes (Figure 6F).”
Quote in the paperSubstantial claim - Findingown data
Mice transplanted with primary human hepatocytes (n = 5) had on average 2.06 μg/mL of human ALBUMIN protein in the mouse bloodstream 1 month post-transplantation.
“Mice transplanted with either hPSC-derived hepatocyte-like cells (n = 7 mice) or primary human hepatocytes (n = 5 mice) had, on average, 120 ± 36 ng/mL and 2.06 μg/mL of human ALBUMIN protein in mouse bloodstream 1 month post-transplantation (Figure 6E).”
Quote in the paperSubstantial claim - Findingown data
Mice transplanted with hPSC-derived hepatocyte-like cells (n = 7) had on average 120 ± 36 ng/mL of human ALBUMIN protein in the mouse bloodstream 1 month post-transplantation.
“Mice transplanted with either hPSC-derived hepatocyte-like cells (n = 7 mice) or primary human hepatocytes (n = 5 mice) had, on average, 120 ± 36 ng/mL and 2.06 μg/mL of human ALBUMIN protein in mouse bloodstream 1 month post-transplantation (Figure 6E).”
Quote in the paperSubstantial claim - Findingown data
NOTCH and TGF-β specified cholangiocytes.
“Later, NOTCH and TGF-β specified cholangiocytes, and thus, NOTCH and brief TGF-β inhibition drove liver bud precursors into 81.5 ± 3.2% FAH+ hepatocyte-like cells by day 18.”
Quote in the paperSubstantial claim - Findingown data
The differentiation approach yielded 88.7%, 77.3%, and 95.9% pure ALBUMIN+ hepatocyte-like cells from the H1, H7, and H9 hPSC lines, respectively, by day 18.
“First, provision of the aforementioned hepatocyte-specifying signals, together with transient inhibition of cholangiocyte-specifying signals TGF-β and NOTCH, yielded 88.7%, 77.3%, and 95.9% pure ALBUMIN+ hepatocyte-like cells from the H1, H7, and H9 hPSC lines, respectively (Figures 4E and S4K), as assessed by intracellular flow cytometry after 18 days of hPSC differentiation.”
Quote in the paperSubstantial claim - Findingown data
CD99 was highly expressed on day-6 liver bud progenitors by comparison to preceding hPSCs or definitive endoderm.
“Finally, CD99 was highly expressed on day-6 liver bud progenitors by comparison to preceding hPSCs or definitive endoderm (DE) (Figures 3C and 3D; Table S1).”
Quote in the paperSubstantial claim - Findingown data
CD184/CXCR4 was enriched in day-2 definitive endoderm in comparison to day-0 hPSCs and day-6 liver bud progenitors.
“Second, CD184/CXCR4 (a known definitive endoderm marker; D'Amour et al., 2005) was enriched in day-2 definitive endoderm in comparison to day-0 hPSCs and day-6 liver bud progenitors (Figure 3E; Table S1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites D'Amour et al., 2005 source
- Findingown data
RA initially blocks intestinal fate during posterior foregut commitment.
“This roadmap revealed that RA initially blocks intestinal fate during posterior foregut commitment; then BMP suppresses pancreatic fate during liver commitment; finally, dual TGF-β and NOTCH blockade extinguish cholangiocyte potential during hepatocyte commitment (Figure 7).”
Quote in the paperSubstantial claim - Findingown data
FACS-sorted Clover+ day-18 cells were significantly enriched for FAH, ALBUMIN, and HGD mRNAs by comparison to Clover− cells.
“Attesting to the faithfulness of the reporter, FACS (fluorescence-activated cell sorting)-sorted Clover+ day-18 cells were significantly enriched for FAH, ALBUMIN, and HGD mRNAs by comparison to Clover− cells (Figure 5F).”
Quote in the paperSubstantial claim - Findingown data
BMP suppresses pancreatic fate during liver commitment.
“This roadmap revealed that RA initially blocks intestinal fate during posterior foregut commitment; then BMP suppresses pancreatic fate during liver commitment; finally, dual TGF-β and NOTCH blockade extinguish cholangiocyte potential during hepatocyte commitment (Figure 7).”
Quote in the paperSubstantial claim - Findingown data
In mice that survived 5 months post-transplantation, human ALBUMIN+ tdTomato+ liver cells resided near the liver vasculature.
“In mice that survived 5 months post-transplantation, human ALBUMIN+ tdTomato+ liver cells resided near the liver vasculature (Figures S6C and S6D).”
Quote in the paperNot a substantial claim - Findingnone given
The hPSC-derived hepatocyte-like day-18 cells express a repertoire of hepatocyte markers and enzymes more highly when compared with cells derived with extant protocols.
“Indeed, the hPSC-derived hepatocyte-like day-18 cells express a repertoire of hepatocyte markers and enzymes more highly when compared with cells derived with extant protocols.”
Quote in the paperSubstantial claim - Findingreasoning
NOTCH and brief TGF-β inhibition drove liver bud precursors into 81.5 ± 3.2% FAH+ hepatocyte-like cells by day 18.
“Later, NOTCH and TGF-β specified cholangiocytes, and thus, NOTCH and brief TGF-β inhibition drove liver bud precursors into 81.5 ± 3.2% FAH+ hepatocyte-like cells by day 18.”
Quote in the paperSubstantial claim - Findingown data
Day-18 hPSC-derived hepatocytes secreted ALBUMIN and FIBRINOGEN proteins into the medium at 5.89 ± 0.71 μg/mL and 1.38 ± 0.26 μg/mL, respectively.
“Second, day-18 hPSC-derived hepatocytes secreted ALBUMIN and FIBRINOGEN proteins into the medium (5.89 ± 0.71 μg/mL and 1.38 ± 0.26 μg/mL, respectively [Figures 4G and S4L]) in the same order of magnitude as the amount secreted by hepatocytes in vivo in human beings (Bernardi et al., 2012; Tennent et al., 2007).”
Quote in the paperSubstantial claim - Findingown data
High insulin levels, together with AAP, greatly promoted the expression of tyrosine metabolic pathway genes PAH, HGD, HPD, TAT, MAI, and FAH and other liver markers by 18 days of differentiation.
“High insulin levels, together with a stabilized ascorbic acid derivative (ascorbic acid-2-phosphate [AAP]) greatly promoted the expression of tyrosine metabolic pathway genes PAH, HGD, HPD, TAT, MAI, and FAH and other liver markers by 18 days of differentiation (Figures S4C and S4F).”
Quote in the paperSubstantial claim - Findingnone given
The surface marker CD99, together with the absence of CD10 and CD184/CXCR4, identifies day-6 liver bud progenitors.
“Third, we also introduce tools to track the process of liver commitment: (1) the surface marker CD99, which, together with the absence of CD10 and CD184/CXCR4, identifies day-6 liver bud progenitors and (2) an FAH-Clover knockin reporter hESC line to track the subsequent generation of FAH+ hepatocyte-like cells.”
Quote in the paperSubstantial claim - Findingown data
72.7% of FRG mice transplanted with hPSC-derived hepatocytes survived longer than negative control mice that were not injected with any cells.
“72.7% of the FRG mice transplanted with hPSC-derived hepatocytes survived longer, compared to negative control mice that were not injected with any cells (Figures 6C and S6F).”
Quote in the paperSubstantial claim - Findingown data
The hPSC-derived liver progenitors generated in the present study expressed significantly higher levels of hepatic transcription factors than the liver cells produced by extant differentiation methods.
“The hPSC-derived liver progenitors generated in the present study expressed significantly higher levels of hepatic transcription factors (Figure 3) than the liver cells produced by extant differentiation methods.”
Quote in the paperSubstantial claim - Findingown data
Dual TGF-β and NOTCH blockade extinguish cholangiocyte potential during hepatocyte commitment.
“This roadmap revealed that RA initially blocks intestinal fate during posterior foregut commitment; then BMP suppresses pancreatic fate during liver commitment; finally, dual TGF-β and NOTCH blockade extinguish cholangiocyte potential during hepatocyte commitment (Figure 7).”
Quote in the paperSubstantial claim - Interpretationown data
The hPSC-derived hepatocyte-like cells improved short-term survival in the Fah-/- Rag2-/- Il2rg-/- mouse model of liver failure.
“the latter improved short-term survival in the Fah–/– Rag2–/– Il2rg–/– mouse model of liver failure.”
- Also stated in: § hPSC-Derived Hepatocytes Engraft the Injured Mouse Liver and Improve Survival during Liver Injury · hedged
“This suggests that engrafted hPSC-derived hepatocytes promoted the survival of the FRG mice.”
Quote in the paperSubstantial claim - Also stated in: § hPSC-Derived Hepatocytes Engraft the Injured Mouse Liver and Improve Survival during Liver Injury · hedged
- Interpretationreasoning
Temporally dynamic manipulation of extracellular signals was imperative to suppress the production of unwanted cell fates across six consecutive developmental junctures.
“Consequently, temporally dynamic manipulation of extracellular signals was imperative to suppress the production of unwanted cell fates across six consecutive developmental junctures.”
Quote in the paperSubstantial claim - Interpretationown data
Liver commitment is executed by signals that exclude alternate lineage options in stepwise fashion across six consecutive lineage choices.
“we demonstrate that liver commitment is executed by signals that exclude alternate lineage options in stepwise fashion across six consecutive lineage choices.”
Quote in the paperSubstantial claim- Rests on an assumption: Liver development from pluripotent cells in vivo entails more than three steps.
- Interpretationcitation
Hepatic transcription factors, when overexpressed, can engender a more mature hepatocyte state.
“This implies that hepatic transcription factors, when overexpressed, can engender a more mature hepatocyte state.”
Quote in the paperSubstantial claim - Interpretationreasoning
Sustained application of these (and other) signals for multiple days may induce extraneous, unwanted lineages.
“This also argues against the sustained application of these (and other) signals for multiple days, which may induce extraneous, unwanted lineages.”
Quote in the paperSubstantial claim - Study design and conductown data
CRISPR/Cas9-mediated gene editing generated a FAH-2A-Clover knockin H1 hESC reporter line in which the FAH coding sequence was left intact.
“To track the expression of FAH at a single-cell level in hPSC-derived hepatocytes, we used CRISPR/Cas9-mediated gene editing to generate a FAH-2A-Clover knockin H1 hESC reporter line in which the FAH coding sequence was left intact (Figures 5C, 5D, and S5D–S5J).”
Quote in the paperSubstantial claim - Interpretationreasoning
This roadmap enables one to logically and dynamically manipulate extracellular signals to systematically restrict the formation of non-liver cell types.
“This roadmap enables one to logically and dynamically manipulate extracellular signals to systematically restrict the formation of non-liver cell types.”
Quote in the paperSubstantial claim - Interpretationown data
Extracellular signals act in a temporally dynamic fashion, being re-interpreted within 24 hr to exert diametrically opposing effects on liver commitment.
“Second, it reveals that extracellular signals act in a temporally dynamic fashion, being re-interpreted within 24 hr to exert diametrically opposing effects on liver commitment.”
Quote in the paperSubstantial claim - Interpretationreasoning
Liver bud progenitors have bipotent capacity at a population level to give rise to either hepatic or biliary fates.
“This suggests the bipotent capacity of liver bud progenitors at a population level to give rise to either hepatic or biliary fates (which remains to be formally demonstrated in vivo by single-cell lineage tracing) and identifies the signals that control the mutually exclusive allocation of ALBUMIN+ hepatocyte-like versus SOX9+ cholangiocyte lineages.”
Quote in the paperSubstantial claim - Premisecitation
Liver transcription factor overexpression can reprogram fibroblasts into more mature hepatocytes.
“Recent progress has shown that liver transcription factor overexpression can reprogram fibroblasts into more mature hepatocytes (Huang et al., 2014; Sekiya and Suzuki, 2011; Song et al., 2016; Yu et al., 2013; Zhu et al., 2014).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationown data
Engrafted hPSC-derived hepatocytes secreted ALBUMIN into the bloodstream, albeit ∼18-fold less than human adult hepatocytes.
“This indicated that engrafted hPSC-derived hepatocytes secreted ALBUMIN into the bloodstream, albeit ∼18-fold less than human adult hepatocytes (Figure 6E).”
Quote in the paperSubstantial claim - Interpretationown data
Multiple endodermal lineages become diversified at successive developmental steps: the same signals are re-iteratively used to accomplish different ends.
“This helped explain how multiple endodermal lineages become diversified at successive developmental steps: the same signals are re-iteratively used to accomplish different ends.”
Quote in the paperSubstantial claim - Interpretationreasoning
Hepatocyte commitment is accomplished in stepwise fashion through signals that exclude alternate fate options (intestines, pancreas, and cholangiocytes) across different lineage branchpoints.
“First, it clarifies how hepatocyte commitment is accomplished in stepwise fashion through signals that exclude alternate fate options (i.e., intestines, pancreas, and cholangiocytes) across different lineage branchpoints.”
Quote in the paperSubstantial claim - Interpretationown data
The roadmap encompasses lineage-specific surface markers useful in tracking successive steps of hepatocyte commitment.
“Third, it encompasses lineage-specific surface markers useful in tracking successive steps of hepatocyte commitment.”
Quote in the paperSubstantial claim - Interpretationown data
Temporally dynamic signals specified liver fate, initially promoting but later inhibiting liver fate.
“Second, we detailed how temporally dynamic signals specified liver fate, initially promoting but later inhibiting liver fate.”
Quote in the paperSubstantial claim - Interpretationreasoning
hPSC-derived hepatocyte-like cells are functional to some extent.
“Ultimately, this demonstrates that hPSC-derived hepatocyte-like cells are functional to some extent, in turn validating the signaling code used for their production.”
Quote in the paperSubstantial claim- Rests on an assumption: The FRG mouse model of hereditary tyrosinemia is a valid model for human liver failure and for assessing the therapeutic potential of human hepatocytes.
- Interpretationreasoning
The signaling code used for production of hPSC-derived hepatocyte-like cells is validated.
“Ultimately, this demonstrates that hPSC-derived hepatocyte-like cells are functional to some extent, in turn validating the signaling code used for their production.”
Quote in the paperSubstantial claim
- May combine two claims. 28
- Classified as probably not a substantial claim. 1
May combine two claims.
Findingown dataThe PSC-to-liver bud differentiation system was significantly more rapid and yielded higher expression of liver bud markers compared to four extant liver differentiation methods.
“Finally, this PSC-to-liver bud differentiation system was significantly more rapid and yielded higher expression of liver bud markers, compared to four extant liver differentiation methods (Avior et al., 2015; Carpentier et al., 2016; Chen et al., 2012; Si-Tayeb et al., 2010; Zhao et al., 2013) (Figures 3A–3C and S3C).”
Quote in the paperSubstantial claim2 of 3 sources checkedMay combine two claims.
Findingown dataSimultaneous activation of TGF-β, BMP, and PKA-but transient suppression of WNT-drove day-3 posterior foregut into day-6 liver bud progenitors while simultaneously blocking pancreatic and midgut/hindgut differentiation.
“In summary, we showed that simultaneous activation of TGF-β, BMP, and PKA—but transient suppression of WNT—drove day-3 posterior foregut into day-6 liver bud progenitors while simultaneously blocking pancreatic and midgut/hindgut differentiation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataForegut specification by day 3 was promoted by TGF-β inhibition and activation of the BMP and FGF pathways.
“Foregut specification by day 3 was also promoted by TGF-β inhibition (Figure 1I) and activation of the BMP (Figure 1J) and FGF pathways (Figures S1D and S1E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataWNT inhibition (using C59) from days 4 to 5 suppressed midgut/hindgut formation and transiently promoted the formation of liver bud progenitors that had the ability to subsequently form hepatocytes.
“Finally, WNT inhibition (using C59) from days 4 to 5 suppressed midgut/hindgut (MHG; posterior endoderm) formation (Figures S1F and S1G) and, instead, transiently promoted the formation of liver bud progenitors that had the ability to subsequently form hepatocytes (Figures S2B and S2C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBMP or FGF activation differentiated foregut into liver bud while blocking pancreas formation; BMP or FGF inhibition suppressed liver formation.
“first, we found that BMP or FGF activation differentiated foregut into liver bud while blocking pancreas formation (Figures 2E, S2D, and S2E); by contrast, BMP or FGF inhibition suppressed liver formation (Figures 2E, S2D, and S2E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTGF-β activation promoted liver bud specification on days 4-6, leading to enhanced liver bud marker expression by day 6.
“Akin to RA signaling, the role for TGF-β in liver specification was also temporally dynamic: TGF-β inhibition initially promoted foregut formation by day 3 (Figure 1I), but 24 hr later, TGF-β activation promoted liver bud specification on days 4–6, leading to enhanced liver bud marker expression by day 6 (Figure 2D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataRA repressed subsequent progression into liver bud progenitors and promoted formation of ODD1+ stomach endoderm on days 4-6.
“While RA initially differentiated endoderm into day-3 posterior foregut (discussed earlier), 24 hr later, it repressed subsequent progression into liver bud progenitors and promoted formation of ODD1+ stomach endoderm on days 4–6 (Figure 2C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenAt the pancreas-liver branchpoint, application of BMP (among other signals) specified liver bud precursors while inhibiting pancreatic fate, generating 94.1 ± 7.35% TBX3+HNF4A+ human liver bud progenitors by day 6 of hPSC differentiation.
“For example, at the pancreas-liver branchpoint, application of BMP (among other signals) specified liver bud precursors while inhibiting pancreatic fate, thus generating 94.1 ± 7.35% TBX3+HNF4A+ human liver bud progenitors by day 6 of hPSC differentiation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCD10 was expressed in 92.6 ± 5.6% of undifferentiated hPSCs but was abruptly down-regulated upon differentiation, being expressed in <2% of cells in day-2 definitive endoderm or day-6 liver bud populations.
“First, CD10 was expressed in 92.6 ± 5.6% of undifferentiated hPSCs but was abruptly down-regulated upon differentiation, being expressed in <2% of cells in day-2 definitive endoderm or day-6 liver bud populations (Figures 3E and S3B; Table S1).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOne month post-transplantation of hPSC-derived hepatocyte-like cells, human ALBUMIN+ liver cells were detected in the mouse liver, some of which were localized near the vasculature.
“1 month post-transplantation of hPSC-derived hepatocyte-like cells, human ALBUMIN+ liver cells were detected in the mouse liver, some of which were localized near the vasculature (Figure 6D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datahPSC-derived hepatocyte-like cells stained positive for periodic acid Schiff (implying glycogen storage) and the liver-specific surface marker ASGR1.
“Fourth, they stained positive for periodic acid Schiff (implying glycogen storage; Figure S4M) as well as the liver-specific surface marker ASGR1 (Figure S4J).”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenOver a brief 24-hr interval, RA activation and TGF-β blockade were necessary to drive definitive endoderm into posterior foregut progenitors, but 24 hr later, they limited further progression of posterior foregut toward a liver bud fate.
“For instance, over a brief 24-hr interval, RA activation and TGF-β blockade were necessary to drive definitive endoderm into posterior foregut progenitors, but 24 hr later, they limited further progression of posterior foregut toward a liver bud fate.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datahPSC-derived hepatocyte-like cells possessed CYP3A4 enzymatic activity at levels 5.9-fold higher than those of HepG2 cells, although they were still 55-fold lower than in primary adult human hepatocytes.
“Third, hPSC-derived hepatocyte-like cells possessed CYP3A4 enzymatic activity at levels 5.9-fold higher than those of HepG2 cells, although they were still 55-fold lower than in primary adult human hepatocytes (Figure 4H).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCombining hepatocyte-specifying signals efficiently generated ALBUMIN+ hepatocyte-like cells by day 18 of differentiation, which displayed various hepatocyte functions in vitro.
“Combining these signals efficiently generated ALBUMIN+ hepatocyte-like cells by day 18 of differentiation, which displayed various hepatocyte functions in vitro.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataActivation of NOTCH and TGF-β, together with insulin, upregulated SOX9, differentiating day-6 liver bud progenitors into CK7+/CK19+ biliary progenitors by day 12 of hPSC differentiation while reducing formation of ALBUMIN+ hepatocyte-like cells.
“Activation of NOTCH and TGF-β, together with insulin, upregulated SOX9, thus differentiating day-6 liver bud progenitors into CK7+/CK19+ biliary progenitors by day 12 of hPSC differentiation (Figures 4B and S4H) (Ogawa et al., 2015; Sampaziotis et al., 2015) while reducing formation of ALBUMIN+ hepatocyte-like cells (Figures 4C and 4D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTreatment with NOTCH inhibitor, AAP, forskolin, or insulin upregulated genes associated with gene ontology classifications pertaining to metabolic processes, indicating these individual manipulations each promote the metabolic competence of hPSC-derived hepatocytes.
“Microarray profiling showed that treatment with NOTCH inhibitor, AAP, forskolin, or insulin upregulated genes associated with gene ontology classifications pertaining to metabolic processes (Figures 4F and S4I; Table S5), asserting that these individual manipulations each promote the metabolic competence of hPSC-derived hepatocytes.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datahPSC-derived hepatocytes engrafted in 7 out of 15 mice and continued to expand in vivo, as shown by an increase in bioluminescence intensity over time.
“Strikingly, hPSC-derived hepatocytes engrafted in 7 out of 15 mice (Figure 6B) and continued to expand in vivo as shown by an increase in bioluminescence intensity over time (Figures 6B, S6B, and S6E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAfter ∼10 weeks of liver injury, all surviving mice had detectable bioluminescence, and mice that initially had little/no bioluminescence had died by this time point.
“After ∼10 weeks of liver injury, all surviving mice had detectable bioluminescence (indicating the presence of transplanted cells); mice that initially had little/no bioluminescence had died by this time point (Figure 6B).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataLiver bud and midgut/hindgut (intestinal) progenitors are transcriptionally distinct lineages and can be produced in mutually exclusive signaling conditions in vitro from hPSCs.
“Taken together, though liver bud and midgut/hindgut (intestinal) progenitors are spatially adjacent in vivo, they are transcriptionally distinct lineages and can be produced in mutually exclusive signaling conditions in vitro from hPSCs.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataWhile there is a common requirement for BMP and FGF in liver and midgut/hindgut specification, signals uniquely specify liver, clarifying how these lineages become segregated from one another.
“Importantly, while there is a common requirement for BMP and FGF in liver and midgut/hindgut specification, we revealed signals that uniquely specify liver, thus clarifying how these lineages become segregated from one another.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataTemporally dynamic manipulation of extracellular signals enables the efficient generation of human liver bud progenitors by day 6 of PSC differentiation, which is ∼2 times faster than extant methods.
“Hence the temporally dynamic manipulation of extracellular signals enables the efficient generation of human liver bud progenitors by day 6 of PSC differentiation, which is ∼2 times faster than extant methods.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe provisional early liver developmental roadmap provides a framework to understand liver commitment at the expense of non-liver fates and may avail the as-yet-unrealized goal of generating fully functional hepatocytes.
“Taken together, the provisional early liver developmental roadmap (Figure 7) provides a framework to understand liver commitment at the expense of non-liver fates and may avail the as-yet-unrealized goal of generating fully functional hepatocytes.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIt is possible to rapidly and efficiently generate hPSC-derived liver bud progenitors and hepatocyte-like cells, the latter of which can engraft in vivo and improve the survival of injured FRG mice.
“Consequently, it is possible to rapidly and efficiently generate hPSC-derived liver bud progenitors and hepatocyte-like cells, the latter of which can engraft in vivo and improve the survival of injured FRG mice.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationreasoningThese liver progenitors provide a fertile venue for subsequent liver maturation efforts and, perhaps, the assembly of enhanced 3D liver "organoids".
“Thus, these liver progenitors provide a fertile venue for subsequent liver maturation efforts and, perhaps, the assembly of enhanced 3D liver “organoids” (Camp et al., 2017; Ogawa et al., 2013; Takebe et al., 2013).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
Interpretationown dataMapping the parallel formation of multiple endodermal lineages provides insight into liver commitment and enables the rational suppression of unwanted, non-liver lineages during hPSC differentiation.
“Here, we demonstrate that mapping the parallel formation of multiple endodermal lineages provides insight into liver commitment and powerfully enables the rational suppression of unwanted, non-liver lineages during hPSC differentiation.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe provisional roadmap for human liver development from PSCs delineates a signaling code for liver development significantly extending beyond the use of prolonged BMP and FGF and illuminates several key features.
“Our provisional roadmap for human liver development from PSCs (Figure 7) delineates a signaling code for liver development significantly extending beyond the use of prolonged BMP and FGF and illuminates several key features.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataWe determined the signals that specify liver fate and suppress unwanted, non-liver lineage(s) at each lineage branchpoint, revealing how alternate fate choices are suppressed in stepwise fashion at successive stages of hepatocyte commitment.
“First, we determined the signals that specify liver fate and suppress unwanted, non-liver lineage(s) at each lineage branchpoint, thus revealing how alternate fate choices are suppressed in stepwise fashion at successive stages of hepatocyte commitment.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe CD99hiCD10−CD184lo/− surface marker profile may be used to track the early specification of, and enrich for, hPSC-derived liver bud progenitors.
“Thus, a CD99hiCD10−CD184lo/− surface marker profile may be used to track the early specification of, and enrich for, hPSC-derived liver bud progenitors (Figure 3F).”
Quote in the paperSubstantial claim
The paper relies on this without support.
Liver development from pluripotent cells in vivo entails more than three steps.
“However, current three-step differentiation approaches may not precisely mirror liver development, as liver development from pluripotent cells in vivo likely entails more than three steps.”
The paper relies on this without support.
The FRG mouse model of hereditary tyrosinemia is a valid model for human liver failure and for assessing the therapeutic potential of human hepatocytes.
“We further tested the ability of day-18 hPSC-derived hepatocytes to ameliorate liver failure in a second mouse model by intrasplenically transplanting them into 4- to 6-week-old adult FRG mice”
“improved short-term survival in the FRG mouse model of hereditary tyrosinemia”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
FRG mouse genotype is spelled two different ways
MinorThe same FRG mouse model is identified with Ilr2g in the introduction but Il2rg in the abstract.
“Fah–/–Rag2–/–Ilr2g–/– (FRG) mouse model of liver injury”
“Fah–/– Rag2–/– Il2rg–/– mouse model of liver failure”
Cites
Vascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170 · cited 3× · see citing works
“Current protocols to differentiate hPSCs toward liver generally commence with (1) ACTIVIN/transforming growth factor β (TGF-β (in the presence or absence of WNT) to initially induce endoderm; followed by (2) BMP and FGF to specify liver progenitors; and, finally, (3) hepatocyte growth factor (HGF), Oncostatin M (OSM),…”
BackgroundDirected differentiation of human pluripotent stem cells into intestinal tissue in vitro
Spence, J. R., Mayhew, C. N., Rankin, S. A., Kuhar, M. F., Vallance, J. E., Tolle, K. A., Hoskins, E. E., Kalinichenko, V. V., Wells, S. I., Zorn, A. M., et al. (2010) · Nature · doi:10.1038/nature09691 · Cited by 1,911 · see citing works
Efficient differentiation of human embryonic stem cells to definitive endoderm
D'Amour, K. A., Agulnick, A. D., Eliazer, S., Kelly, O. G., Kroon, E., & Baetge, E. E. (2005) · Nature Biotechnology · doi:10.1038/nbt1163 · Cited by 1,730 · cited 1× · see citing works
“Second, CD184/CXCR4 (a known definitive endoderm marker; D'Amour et al., 2005) was enriched in day-2 definitive endoderm in comparison to day-0 hPSCs and day-6 liver bud progenitors (Figure 3E; Table S1).”
ResultHighly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells
Si-Tayeb, K., Noto, F. K., Nagaoka, M., Li, J., Battle, M. A., Duris, C., North, P. E., Dalton, S., & Duncan, S. A. (2010) · Hepatology · doi:10.1002/hep.23354 · Cited by 1,282 · cited 10× · see citing works
“Given that previous differentiation protocols yielded hPSC-derived hepatocyte-like cells also displaying some extent of in vitro functionality (Espejel et al., 2010; Ogawa et al., 2013; Rashid et al., 2010; Si-Tayeb et al., 2010; Takebe et al., 2013; Zhao et al., 2013), we focused next on expression of tyrosine metabo…”
BackgroundResultInfluentialModelling human development and disease in pluripotent stem-cell-derived gastric organoids
McCracken, K. W., Catá, E. M., Crawford, C. M., Sinagoga, K. L., Schumacher, M., Rockich, B. E., Tsai, Y.-H., Mayhew, C. N., Spence, J. R., Zavros, Y., et al. (2014) · Nature · doi:10.1038/nature13863 · Cited by 980 · cited 1× · see citing works
“Thus, RA is crucial for human posterior foregut specification, consistent with the role for RA in generating foregut derivatives such as stomach endoderm in vitro (McCracken et al., 2014) and how inhibiting RA synthesis abrogates both liver and pancreas formation in zebrafish embryos (Stafford and Prince, 2002).”
BackgroundForcing cells to change lineages
Graf, T., & Enver, T. (2009) · Nature · doi:10.1038/nature08533 · Cited by 899 · cited 1× · see citing works
“A quintessential goal of developmental biology is to understand how stem cells and progenitors commit to a singular lineage among multiple alternate fate choices (Graf and Enver, 2009).”
BackgroundClonal analysis of epiblast fate during germ layer formation in the mouse embryo
Lawson, K. A., Meneses, J. J., & Pedersen, R. A. (1991) · Development · doi:10.1242/dev.113.3.891 · Cited by 881 · see citing works
Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors
Sekiya, S., & Suzuki, A. (2011) · Nature · doi:10.1038/nature10263 · Cited by 846 · see citing works
Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice
Azuma, H., Paulk, N., Ranade, A., Dorrell, C., Al-Dhalimy, M., Ellis, E., Strom, S., Kay, M. A., Finegold, M., & Grompe, M. (2007) · Nature Biotechnology · doi:10.1038/nbt1326 · Cited by 835 · cited 9× · see citing works
“NTBC (Yecuris, 20- 0026) was dissolved in sodium carbonate to generate 1 mg/mL stock solution.”
BackgroundInfluentialVertebrate Endoderm Development and Organ Formation
Zorn, A. M., & Wells, J. M. (2009) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113344 · Cited by 812 · see citing works
Initiation of Mammalian Liver Development from Endoderm by Fibroblast Growth Factors
Jung, J., Zheng, M., Goldfarb, M., & Zaret, K. S. (1999) · Science · doi:10.1126/science.284.5422.1998 · Cited by 721 · cited 16× · see citing works
“B) qPCR gene expression of day-18 hepatocyte markers after inhibition (BMS) or activation of retinoid signaling (using ATRA, 2 µM or various doses of TTNPB, 10-100 nM) in the presence of base media condition A83BF (A83BF: A8301, 1 µM; BMP4, 30 ng/mL; FGF2, 10 ng/mL) on the day 2-3 interval.”
BackgroundInfluentialRossi, J. M., Dunn, N. R., Hogan, B. L. M., & Zaret, K. S. (2001) · Genes & Development · doi:10.1101/gad.904601 · Cited by 646 · cited 19× · see citing works
“B) qPCR gene expression of day-18 hepatocyte markers after inhibition (BMS) or activation of retinoid signaling (using ATRA, 2 µM or various doses of TTNPB, 10-100 nM) in the presence of base media condition A83BF (A83BF: A8301, 1 µM; BMP4, 30 ng/mL; FGF2, 10 ng/mL) on the day 2-3 interval.”
BackgroundResultInfluentialDirected differentiation of human embryonic stem cells into functional hepatic cells†
Cai, J., Zhao, Y., Liu, Y., Ye, F., Song, Z., Qin, H., Meng, S., Chen, Y., Zhou, R., Song, X., et al. (2007) · Hepatology · doi:10.1002/hep.21582 · Cited by 628 · cited 2× · see citing works
“Current protocols to differentiate hPSCs toward liver generally commence with (1) ACTIVIN/transforming growth factor β (TGF-β (in the presence or absence of WNT) to initially induce endoderm; followed by (2) BMP and FGF to specify liver progenitors; and, finally, (3) hepatocyte growth factor (HGF), Oncostatin M (OSM),…”
BackgroundMultilineage communication regulates human liver bud development from pluripotency
Camp, J. G., Sekine, K., Gerber, T., Loeffler-Wirth, H., Binder, H., Gac, M., Kanton, S., Kageyama, J., Damm, G., Seehofer, D., et al. (2017) · Nature · doi:10.1038/nature22796 · Cited by 621 · cited 2× · see citing works
“Thus, these liver progenitors provide a fertile venue for subsequent liver maturation efforts and, perhaps, the assembly of enhanced 3D liver “organoids” (Camp et al., 2017; Ogawa et al., 2013; Takebe et al., 2013).”
BackgroundModeling inherited metabolic disorders of the liver using human induced pluripotent stem cells
Rashid, S. T., Corbineau, S., Hannan, N. R. F., Marciniak, S. J., Miranda, E., Alexander, G., Huang‐Doran, I., Griffin, J. L., Ährlund‐Richter, L., Skepper, J. N., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43122 · Cited by 598 · cited 3× · see citing works
“Current protocols to differentiate hPSCs toward liver generally commence with (1) ACTIVIN/transforming growth factor β (TGF-β (in the presence or absence of WNT) to initially induce endoderm; followed by (2) BMP and FGF to specify liver progenitors; and, finally, (3) hepatocyte growth factor (HGF), Oncostatin M (OSM),…”
BackgroundHepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control.Preprint
Gualdi, R., Bossard, P., Zheng, M., Hamada, Y., Coleman, J. R., & Zaret, K. S. (1996) · Genes & Development · doi:10.1101/gad.10.13.1670 · Cited by 590 · cited 1× · see citing works
“Hence, analogous to embryonic explant cultures (Gualdi et al., 1996; Serls et al., 2005), PSC differentiation might allow us to uncover the combinations and timings of signals that specify cell fate at a level of detail difficult to achieve in vivo.”
BackgroundStem/progenitor cells in liver development, homeostasis, regeneration, and reprogramming
Miyajima, A., Tanaka, M., & Itoh, T. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.04.010 · Cited by 570 · cited 1× · see citing works
“Pluripotent cells develop into liver cells through multiple consecutive branching lineage choices, which have been partially delineated through studies of early vertebrate embryos (Duncan, 2003; Gordillo et al., 2015; Lemaigre, 2009; Lewis and Tam, 2006; Miyajima et al., 2014) but remain to be fully elucidated.”
BackgroundDirect Reprogramming of Human Fibroblasts to Functional and Expandable Hepatocytes
Huang, P., Zhang, L., Gao, Y., He, Z., Yao, D., Wu, Z., Cen, J., Chen, X., Liu, C., Hu, Y., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.01.003 · Cited by 560 · cited 1× · see citing works
“Recent progress has shown that liver transcription factor overexpression can reprogram fibroblasts into more mature hepatocytes (Huang et al., 2014; Sekiya and Suzuki, 2011; Song et al., 2016; Yu et al., 2013; Zhu et al., 2014).”
BackgroundOverturf, K., Al-Dhalimy, M., Tanguay, R., Brantly, M., Ou, C.-N., Finegold, M., & Grompe, M. (1996) · Nature Genetics · doi:10.1038/ng0396-266 · Cited by 549 · cited 9× · see citing works
“NTBC (Yecuris, 20- 0026) was dissolved in sodium carbonate to generate 1 mg/mL stock solution.”
BackgroundInfluentialThomas, P. Q., Brown, A., & Beddington, R. S. P. (1998) · Development · doi:10.1242/dev.125.1.85 · Cited by 528 · see citing works
Differentiation and Transplantation of Human Embryonic Stem Cell–Derived Hepatocytes
Basma, H., Soto–Gutiérrez, A., Yannam, G. R., Liu, L., Ito, R., Yamamoto, T., Ellis, E. C. S., Carson, S. D., Sato, S., Chen, Y., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.047 · Cited by 509 · cited 1× · see citing works
“There has been major headway in reconstituting enriched populations of hepatocyte-like cells from human PSCs (hPSCs) (Agarwal et al., 2008; Basma et al., 2009; Cai et al., 2007; Carpentier et al., 2014, 2016; Espejel et al., 2010; Han et al., 2012; Ogawa et al., 2013; Rashid et al., 2010; Si-Tayeb et al., 2010; Song e…”
BackgroundEfficient generation of hepatocyte-like cells from human induced pluripotent stem cells
Song, Z., Cai, J., Liu, Y., Zhao, D., Yong, J., Duo, S., Song, X., Guo, Y., Zhao, Y., Qin, H., et al. (2009) · Cell Research · doi:10.1038/cr.2009.107 · Cited by 499 · cited 2× · see citing works
“Current protocols to differentiate hPSCs toward liver generally commence with (1) ACTIVIN/transforming growth factor β (TGF-β (in the presence or absence of WNT) to initially induce endoderm; followed by (2) BMP and FGF to specify liver progenitors; and, finally, (3) hepatocyte growth factor (HGF), Oncostatin M (OSM),…”
BackgroundTouboul, T., Hannan, N. R. F., Corbineau, S., Martinez, A., Martinet, C., Branchereau, S., Goulinet, S., Strick‐Marchand, H., Pedersen, R. A., Santo, J. P. D., et al. (2009) · Hepatology · doi:10.1002/hep.23506 · Cited by 499 · cited 5× · see citing works
“The composition of CDM2 base medium has been previously reported (Loh et al., 2014; Loh et al., 2016; Touboul et al., 2010).”
BackgroundResultInfluentialLoh, K. M., Chen, A. C., Koh, P. W., Deng, T. Z., Sinha, R., Tsai, J. M., Barkal, A. A., Shen, K., Jain, R., Morganti, R. M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.011 · Cited by 493 · see citing works
Self-citationBhushan, A., Itoh, N., Kato, S., Thiery, J. P., Czernichow, P., Bellusci, S., & Scharfmann, R. (2001) · Development · doi:10.1242/dev.128.24.5109 · Cited by 459 · see citing works
Hay, D. C., Zhao, D., Fletcher, J., Hewitt, Z. A., McLean, D., Urruticoechea-Uriguen, A., Black, J. R., Elcombe, C., Ross, J. A., Wolf, R., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0718 · Cited by 441 · cited 1× · see citing works
“35% HNF4A+ pure liver bud progenitors were produced (Figure S3A), whereas HNF4A + liver progenitors were typically formed on later days (by day 10–14) in other differentiation protocols (Carpentier et al., 2016; Hay et al., 2008; Si-Tayeb et al., 2010; Zhao et al., 2013).”
BackgroundBMP-4 is required for hepatic specification of mouse embryonic stem cell–derived definitive endoderm
Gouon–Evans, V., Boussemart, L., Gadue, P. J., Nierhoff, D., Koehler, C. I., Kubo, A., Shafritz, D. A., & Keller, G. M. (2006) · Nature Biotechnology · doi:10.1038/nbt1258 · Cited by 426 · cited 2× · see citing works
“Previous pathfinding PSC-to-liver differentiation studies focused solely on liver differentiation and mostly used prolonged BMP and FGF to induce liver from endoderm (Gouon-Evans et al., 2006; Shiraki et al., 2008; Si-Tayeb et al., 2010; Spence et al., 2011b; Touboul et al., 2010; Zhao et al., 2013).”
BackgroundLoh, K. M., Ang, L. T., Zhang, J., Kumar, V., Ang, J., Auyeong, J. Q., Lee, K. L., Choo, S. H., Lim, C. Y. Y., Nichane, M., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2013.12.007 · Cited by 418 · cited 7× · see citing works
“First, anterior primitive streak was specified using Definitive Endoderm Induction Medium A for 24 hours, followed by Definitive Endoderm Induction medium B for 24 hours to induce definitive endoderm (Gibco, A27654SA) (Loh et al., 2014).”
InfluentialSelf-citationEfficient Differentiation of Functional Hepatocytes from Human Embryonic Stem Cells
Agarwal, S., Holton, K., & Lanza, R. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1102 · Cited by 402 · cited 1× · see citing works
“There has been major headway in reconstituting enriched populations of hepatocyte-like cells from human PSCs (hPSCs) (Agarwal et al., 2008; Basma et al., 2009; Cai et al., 2007; Carpentier et al., 2014, 2016; Espejel et al., 2010; Han et al., 2012; Ogawa et al., 2013; Rashid et al., 2010; Si-Tayeb et al., 2010; Song e…”
BackgroundSampaziotis, F., de Brito, M. C., Madrigal, P., Bertero, A., Saeb‐Parsy, K., Soares, F. A. C., Schrumpf, E., Melum, E., Karlsen, T. H., Bradley, J. A., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3275 · Cited by 398 · see citing works
The formation of mesodermal tissues in the mouse embryo during gastrulation and early organogenesis
Tam, P., & Beddington, R. S. P. (1987) · Development · doi:10.1242/dev.99.1.109 · Cited by 387 · see citing works
Orchestrating liver development
Gordillo, M., Evans, T., & Gouon-Evans, V. (2015) · Development · doi:10.1242/dev.114215 · Cited by 375 · cited 1× · see citing works
“Pluripotent cells develop into liver cells through multiple consecutive branching lineage choices, which have been partially delineated through studies of early vertebrate embryos (Duncan, 2003; Gordillo et al., 2015; Lemaigre, 2009; Lewis and Tam, 2006; Miyajima et al., 2014) but remain to be fully elucidated.”
BackgroundMcLin, V. A., Rankin, S. A., & Zorn, A. M. (2007) · Development · doi:10.1242/dev.001230 · Cited by 364 · cited 1× · see citing works
“This is consistent with how WNT blocks foregut formation and, instead, specifies midgut/hindgut in Xenopus (McLin et al., 2007) but subsequently promotes proliferation of liver progenitors (Sekine et al.”
BackgroundDirected differentiation of cholangiocytes from human pluripotent stem cells
Ogawa, M., Ogawa, S., Bear, C. E., Ahmadi, S., Chin, S., Li, B., Grompe, M., Keller, G. M., Kamath, B. M., & Ghanekar, A. (2015) · Nature Biotechnology · doi:10.1038/nbt.3294 · Cited by 318 · cited 1× · see citing works
“Activation of NOTCH and TGF-β, together with insulin, upregulated SOX9, thus differentiating day-6 liver bud progenitors into CK7+/CK19+ biliary progenitors by day 12 of hPSC differentiation (Figures 4B and S4H) (Ogawa et al., 2015; Sampaziotis et al., 2015) while reducing formation of ALBUMIN + hepatocyte-like cells…”
BackgroundDifferent thresholds of fibroblast growth factors pattern the ventral foregut into liver and lung
Serls, A. E., Doherty, S., Parvatiyar, P., Wells, J. M., & Deutsch, G. H. (2004) · Development · doi:10.1242/dev.01570 · Cited by 313 · cited 1× · see citing works
“Hence, analogous to embryonic explant cultures (Gualdi et al., 1996; Serls et al., 2005), PSC differentiation might allow us to uncover the combinations and timings of signals that specify cell fate at a level of detail difficult to achieve in vivo.”
BackgroundRetinoic acid signaling is required for a critical early step in zebrafish pancreatic development
Stafford, D., & Prince, V. E. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00929-6 · Cited by 309 · see citing works
Human plasma fibrinogen is synthesized in the liver
Tennent, G. A., Brennan, S. O., Stangou, A. J., O'Grady, J., Hawkins, P. N., & Pepys, M. B. (2007) · Blood · doi:10.1182/blood-2006-08-040956 · Cited by 304 · cited 1× · see citing works
“26 μg/mL, respectively [Figures 4G and S4L]) in the same order of magnitude as the amount secreted by hepatocytes in vivo in human beings (Bernardi et al., 2012; Tennent et al., 2007).”
BackgroundSox17 Regulates Organ Lineage Segregation of Ventral Foregut Progenitor Cells
Spence, J. R., Lange, A. W., Lin, S. J., Kaestner, K. H., Lowy, A. M., Kim, I., Whitsett, J. A., & Wells, J. M. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.05.012 · Cited by 302 · cited 1× · see citing works
“Definitive endoderm is the common progenitor to epithelial cells in diverse internal organs, including the liver, pancreas, and intestines (Spence et al., 2009; Tremblay and Zaret, 2005) (Figure 1A).”
BackgroundTremblay, K. D., & Zaret, K. S. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.01.003 · Cited by 299 · see citing works
Sekine, S., Lan, B. Y., Bedolli, M., Feng, S., & Hebrok, M. (2006) · Hepatology · doi:10.1002/hep.21131 · Cited by 295 · see citing works
Chen, Y.-F., Tseng, C.-Y., Wang, H.-W., Kuo, H.-C., Yang, V. W., & Lee, O. K. (2012) · Hepatology · doi:10.1002/hep.24790 · Cited by 291 · cited 3× · see citing works
“…generated by 4 methods: SR2 (the method described in the present work) and previously-reported methods (Carpentier et al., 2016; Avior et al., 2015; Chen et al., 2012) were stained for ALBUMIN (ALB) and Alpha1 anti-trypsin (AAT) with a DAPI nuclear counterstain and multiple fields were stitched…”
MethodMouse liver repopulation with hepatocytes generated from human fibroblasts
Zhu, S.-Y., Rezvani, M., Harbell, J., Mattis, A. N., Wolfe, A., Benet, L., Willenbring, H., & Ding, S. (2014) · Nature · doi:10.1038/nature13020 · Cited by 266 · cited 2× · see citing works
“Recent progress has shown that liver transcription factor overexpression can reprogram fibroblasts into more mature hepatocytes (Huang et al., 2014; Sekiya and Suzuki, 2011; Song et al., 2016; Yu et al., 2013; Zhu et al., 2014).”
BackgroundWang, A., Yue, F., Li, Y., Xie, R., Harper, T. C., Patel, N. A., Muth, K., Palmer, J., Qiu, Y., Wang, J., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.02.013 · Cited by 263 · cited 1× · see citing works
“manipulated with the same dynamism to guide efficient differentiation as cells pass through transient windows of inductive competence (Loh et al., 2014, 2016; Wang et al., 2015).”
BackgroundLemaigre, F. P. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.035 · Cited by 263 · see citing works
Dynamic Signaling Network for the Specification of Embryonic Pancreas and Liver Progenitors
Wandzioch, E., & Zaret, K. (2009) · Science · doi:10.1126/science.1174497 · Cited by 249 · see citing works
Vertebrate intestinal endoderm development
Spence, J. R., Lauf, R., & Shroyer, N. F. (2011) · Developmental Dynamics · doi:10.1002/dvdy.22540 · Cited by 217 · see citing works
Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver Fibrosis
Song, G., Pacher, M., Balakrishnan, A., Yuan, Q., Tsay, H.-C., Yang, D., Reetz, J., Brandes, S., Dai, Z., Pützer, B. M., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.01.010 · Cited by 208 · cited 1× · see citing works
“Recent progress has shown that liver transcription factor overexpression can reprogram fibroblasts into more mature hepatocytes (Huang et al., 2014; Sekiya and Suzuki, 2011; Song et al., 2016; Yu et al., 2013; Zhu et al., 2014).”
BackgroundBmp and Fgf signaling are essential for liver specification in zebrafish
Shin, D., Shin, C. H., Tucker, J. A., Ober, E. A., Rentzsch, F., Poss, K. D., Hammerschmidt, M., Mullins, M. C., & Stainier, D. Y. R. (2007) · Development · doi:10.1242/dev.000281 · Cited by 207 · cited 17× · see citing works
“B) qPCR gene expression of day-18 hepatocyte markers after inhibition (BMS) or activation of retinoid signaling (using ATRA, 2 µM or various doses of TTNPB, 10-100 nM) in the presence of base media condition A83BF (A83BF: A8301, 1 µM; BMP4, 30 ng/mL; FGF2, 10 ng/mL) on the day 2-3 interval.”
BackgroundResultInfluentialCascio, S. M., & Zaret, K. (1991) · Development · doi:10.1242/dev.113.1.217 · Cited by 204 · see citing works
Jacquemin, P., Lemaigre, F., & Rousseau, G. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00115-5 · Cited by 187 · cited 1× · see citing works
“Since Tbx3, Afp, Prox1, Cebpa, Hnf4a, Hnf6, and Hnf1b (Jacquemin et al., 2003; Lokmane et al., 2008; Lüdtke et al., 2009; Shiojiri et al., 2004; Suzuki et al., 2008a) are expressed in E9.”
BackgroundEspejel, S., Roll, G. R., McLaughlin, K. J., Lee, A. Y., Zhang, J. Y., Laird, D. J., Okita, K., Yamanaka, S., & Willenbring, H. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43267 · Cited by 187 · cited 2× · see citing works
“There has been major headway in reconstituting enriched populations of hepatocyte-like cells from human PSCs (hPSCs) (Agarwal et al., 2008; Basma et al., 2009; Cai et al., 2007; Carpentier et al., 2014, 2016; Espejel et al., 2010; Han et al., 2012; Ogawa et al., 2013; Rashid et al., 2010; Si-Tayeb et al., 2010; Song e…”
BackgroundReprogramming Fibroblasts into Bipotential Hepatic Stem Cells by Defined Factors
Yu, B., He, Z., You, P., Han, Q., Xiang, D., Chen, F., Wang, M., Liu, C., Lin, X., Borjigin, U., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.06.017 · Cited by 177 · cited 1× · see citing works
“Recent progress has shown that liver transcription factor overexpression can reprogram fibroblasts into more mature hepatocytes (Huang et al., 2014; Sekiya and Suzuki, 2011; Song et al., 2016; Yu et al., 2013; Zhu et al., 2014).”
BackgroundMechanisms controlling early development of the liver
Duncan, S. A. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(02)00328-3 · Cited by 169 · see citing works
Suzuki, A., Sekiya, S., Onishi, M., Oshima, N., Kiyonari, H., Nakauchi, H., & Taniguchi, H. (2008) · Hepatology · doi:10.1002/hep.22558 · Cited by 167 · see citing works
Definitive endoderm of the mouse embryo: Formation, cell fates, and morphogenetic function
Lewis, S. L., & Tam, P. P. L. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20846 · Cited by 164 · see citing works
BMP signalling regulates anteroposterior endoderm patterning in zebrafish
Tiso, N., Filippi, A., Pauls, S., Bortolussi, M., & Argenton, F. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(02)00252-6 · Cited by 161 · cited 1× · see citing works
“Unexpectedly, although BMP inhibition expanded the foregut domain in Xenopus and zebrafish (Rankin et al., 2011; Tiso et al., 2002), conversely, day-3 BMP inhibition reduced the competence of hPSC-derived foregut progenitors to later differentiate into liver bud progenitors (Figure 1J).”
BackgroundOgawa, S., Surapisitchat, J., Virtanen, C., Ogawa, M., Niapour, M., Sugamori, K. S., Wang, S., Tamblyn, L., Guillemette, C., Hoffmann, E., et al. (2013) · Development · doi:10.1242/dev.090266 · Cited by 161 · cited 5× · see citing works
“Thus, these liver progenitors provide a fertile venue for subsequent liver maturation efforts and, perhaps, the assembly of enhanced 3D liver “organoids” (Camp et al., 2017; Ogawa et al., 2013; Takebe et al., 2013).”
BackgroundInfluentialBmp2 Signaling Regulates the Hepatic versus Pancreatic Fate Decision
Chung, W., Shin, C. H., & Stainier, D. Y. R. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.08.019 · Cited by 144 · cited 19× · see citing works
“B) qPCR gene expression of day-18 hepatocyte markers after inhibition (BMS) or activation of retinoid signaling (using ATRA, 2 µM or various doses of TTNPB, 10-100 nM) in the presence of base media condition A83BF (A83BF: A8301, 1 µM; BMP4, 30 ng/mL; FGF2, 10 ng/mL) on the day 2-3 interval.”
BackgroundResultInfluentialZonation of metabolism and gene expression in liver
Jungermann, K. A. (1995) · Histochemistry and Cell Biology · doi:10.1007/bf01454004 · Cited by 140 · cited 1× · see citing works
“, 2009) but diversify to form multiple functionally distinct hepatocyte subsets after birth (Colnot and Perret, 2011; Jungermann, 1995; Shiojiri et al., 1995; Spijkers et al., 2001), including periportal or pericentral hepatocytes that encircle, respectively, either portal or central veins (Smith and Campbell, 1988).”
BackgroundEngrafted human stem cell–derived hepatocytes establish an infectious HCV murine model
Carpentier, A., Tesfaye, A., Chu, V., Nimgaonkar, I., Zhang, F., Lee, S. B., Thorgeirsson, S. S., Feinstone, S. M., & Liang, T. J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75456 · Cited by 140 · cited 1× · see citing works
“Current protocols to differentiate hPSCs toward liver generally commence with (1) ACTIVIN/transforming growth factor β (TGF-β (in the presence or absence of WNT) to initially induce endoderm; followed by (2) BMP and FGF to specify liver progenitors; and, finally, (3) hepatocyte growth factor (HGF), Oncostatin M (OSM),…”
BackgroundSuzuki, A., Sekiya, S., Büscher, D., Izpisúa Belmonte, J. C., & Taniguchi, H. (2008) · Development · doi:10.1242/dev.016634 · Cited by 136 · see citing works
Bayha, E., Jørgensen, M. C., Serup, P., & Grapin‐Botton, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005845 · Cited by 121 · cited 1× · see citing works
“Hence, our findings reconcile conflicting findings that RA is, overall, required for zebrafish liver induction (Stafford and Prince, 2002) but that RA-coupled beads inhibit liver bud marker formation in Hamburger Hamilton Stage 10 (HH10)-stage zebrafish embryos (Bayha et al., 2009); there is a temporally dynamic requi…”
ResultLüdtke, T. H. ‐., Christoffels, V. M., Petry, M., & Kispert, A. (2009) · Hepatology · doi:10.1002/hep.22700 · Cited by 117 · cited 1× · see citing works
“Since Tbx3, Afp, Prox1, Cebpa, Hnf4a, Hnf6, and Hnf1b (Jacquemin et al., 2003; Lokmane et al., 2008; Lüdtke et al., 2009; Shiojiri et al., 2004; Suzuki et al., 2008a) are expressed in E9.”
BackgroundHaridass, D., Yuan, Q., Becker, P. D., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090117 · Cited by 114 · cited 1× · see citing works
“Indeed, certain differentiation protocols generate impure populations containing a subset of hPSC-derived liver cells; upon transplantation, these impure populations yielded tumors (Haridass et al., 2009).”
BackgroundDifferentiation of mouse and human embryonic stem cells into hepatic lineages
Shiraki, N., Umeda, K., Sakashita, N., Takeya, M., Kume, K., & Kume, S. (2008) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01201.x · Cited by 112 · cited 1× · see citing works
“Previous pathfinding PSC-to-liver differentiation studies focused solely on liver differentiation and mostly used prolonged BMP and FGF to induce liver from endoderm (Gouon-Evans et al., 2006; Shiraki et al., 2008; Si-Tayeb et al., 2010; Spence et al., 2011b; Touboul et al., 2010; Zhao et al., 2013).”
BackgroundWnt signaling specifies and patterns intestinal endoderm
Sherwood, R. I., Maehr, R., Mazzoni, E. O., & Melton, D. A. (2011) · Mechanisms of Development · doi:10.1016/j.mod.2011.07.005 · Cited by 111 · cited 1× · see citing works
“Reciprocally, hPSC-derived liver bud progenitors did not express CDX or HOX genes (Figures 2I and S2A), which are markers of the midgut/hindgut, a developmentally related lineage that emanates from adjacent posterior endoderm and is also specified by BMP and FGF signals (Sherwood et al., 2011; Spence et al., 2011b).”
BackgroundCrucial role of vHNF1 in vertebrate hepatic specification
Lokmane, L., Haumaître, C., García-Villalba, P., Anselme, I., Schneider-Maunoury, S., & Cereghini, S. (2008) · Development · doi:10.1242/dev.023010 · Cited by 106 · cited 1× · see citing works
“Since Tbx3, Afp, Prox1, Cebpa, Hnf4a, Hnf6, and Hnf1b (Jacquemin et al., 2003; Lokmane et al., 2008; Lüdtke et al., 2009; Shiojiri et al., 2004; Suzuki et al., 2008a) are expressed in E9.”
BackgroundHuman albumin in the management of complications of liver cirrhosis
Bernardi, M., Maggioli, C., & Zaccherini, G. (2012) · Critical Care · doi:10.1186/cc11218 · Cited by 99 · cited 1× · see citing works
“26 μg/mL, respectively [Figures 4G and S4L]) in the same order of magnitude as the amount secreted by hepatocytes in vivo in human beings (Bernardi et al., 2012; Tennent et al., 2007).”
BackgroundCarpentier, A., Nimgaonkar, I., Chu, V., Xia, Y., Hu, Z., & Liang, T. J. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.03.009 · Cited by 90 · cited 25× · see citing works
“Finally, the cells were washed once with 100 ng/mL DAPI/PBS once and twice with 1x PBS before visualization using Zeiss Axio Vision.”
BackgroundMethodResultInfluentialDistribution of glutamine synthetase and carbamoyl-phosphate synthetase I in vertebrate liver.
Smith, D. D., & Campbell, J. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.1.160 · Cited by 89 · see citing works
Highsmith, W. E., Burch, L. H., Zhou, Z., Olsen, J. C., Strong, T. V., Smith, T., Friedman, K. J., Silverman, L. M., Boucher, R. C., Collins, F. S., et al. (1997) · Human Mutation · doi:10.1002/(sici)1098-1004(1997)9:4 · Cited by 89 · see citing works
Avior, Y., Levy, G., Zimerman, M., Kitsberg, D., Schwartz, R., Sadeh, R., Moussaieff, A., Cohen, M., Itskovitz‐Eldor, J., & Nahmias, Y. (2015) · Hepatology · doi:10.1002/hep.27803 · Cited by 88 · cited 6× · see citing works
“Based on Avior et al., 2015 and Chen et al., 2012, human ESCs were treated with 100ng/mL ACTIVIN, 50ng/mL WNT3A and 10ng/mL HGF for 3 days in 2% B27 RPMI supplemented with 1mM Glutamax.”
BackgroundMethodResultInfluentialHepatic induction in the avian embryo: Specificity of reactive endoderm and inductive mesoderm
Fukuda-Taira, S. (1981) · Development · doi:10.1242/dev.63.1.111 · Cited by 87 · see citing works
Grapin‐Botton, A. (2005) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041946ag · Cited by 85 · cited 1× · see citing works
“5, endoderm is patterned along the anterior-posterior axis to broadly form the anterior foregut, posterior foregut, and midgut/hindgut (Grapin-Botton, 2005; Zorn and Wells, 2009).”
BackgroundA gene regulatory network controlling hhex transcription in the anterior endoderm of the organizer
Rankin, S. A., Kormish, J. D., Kofron, M. J., Jegga, A. G., & Zorn, A. M. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2010.11.037 · Cited by 69 · cited 1× · see citing works
“Unexpectedly, although BMP inhibition expanded the foregut domain in Xenopus and zebrafish (Rankin et al., 2011; Tiso et al., 2002), conversely, day-3 BMP inhibition reduced the competence of hPSC-derived foregut progenitors to later differentiate into liver bud progenitors (Figure 1J).”
BackgroundLabelle, Y., Phaneuf, D., Leclerc, B., & M.Tanguay, R. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.7.941 · Cited by 67 · cited 1× · see citing works
“FRG mice are an immunodeficient mouse model of tyrosinemia type I, an inherited liver failure syndrome caused by FAH mutations in patients (Labelle et al., 1993; St-Louis and Tanguay, 1997).”
BackgroundZhao, D., Chen, S., Duo, S., Xiang, C., Jia, J., Guo, M., Lai, W., Lu, S., & Deng, H. (2012) · Cell Research · doi:10.1038/cr.2012.144 · Cited by 53 · cited 15× · see citing works
“Given that previous differentiation protocols yielded hPSC-derived hepatocyte-like cells also displaying some extent of in vitro functionality (Espejel et al., 2010; Ogawa et al., 2013; Rashid et al., 2010; Si-Tayeb et al., 2010; Takebe et al., 2013; Zhao et al., 2013), we focused next on expression of tyrosine metabo…”
BackgroundMethodResultInfluentialColnot, S., & Perret, C. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_2 · Cited by 50 · see citing works
Prostaglandin E2 Regulates Liver versus Pancreas Cell-Fate Decisions and Endodermal Outgrowth
Nissim, S., Sherwood, R. I., Wucherpfennig, J. I., Saunders, D. C., Harris, J. M., Esain, V., Carroll, K. J., Frechette, G. M., Kim, A. J., Hwang, K. L., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.01.006 · Cited by 49 · cited 1× · see citing works
“, 8-bromo-cAMP) also potently specified liver bud from foregut (Figure 2F), supporting the notion that prostaglandin E2 specifies zebrafish liver progenitors by activating the PKA cascade (Nissim et al., 2014).”
BackgroundShiojiri, N., Takeshita, K., Yamasaki, H., & Iwata, T. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.07.011 · Cited by 48 · see citing works
Towards consistent generation of pancreatic lineage progenitors from human pluripotent stem cells
Rostovskaya, M., Bredenkamp, N., & Smith, A. G. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2014.0365 · Cited by 43 · cited 1× · see citing works
“These nearly pure day-2 endoderm populations, whose purity has been corroborated by other groups (Rostovskaya et al., 2015), provided an optimal starting point to examine signals that could further generate Ang et al.”
BackgroundMolecular Pathology of Liver Diseases
Nagy, L. E. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.020 · Cited by 41 · see citing works
Induction de l’endoderme pré-hépatique par le mésoderme de l’aire cardiaque chez l’embryon de poulet
Douarin, P. N. L. (1964) · Development · doi:10.1242/dev.12.4.651 · Cited by 39 · see citing works
Chern, E., Sekine, K., Nakamura, K., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.064 · Cited by 33 · cited 3× · see citing works
“D Adult mouse liver (injected as pups) 4-5 months post-injury photons/sec/cm2/sr Adult mouse liver (injected in adults) 2 month post-injury E Control (media) 8 weeks day 18 hPSC-derived hepatocytes (media + cells) 0.15 8.0 106photons/sec/cm2/sr 1 week 4 weeks A -NTBC 6 wk old Luciferase+ hepatocyte-like cells (d18) Po…”
BackgroundInfluentialShiojiri, N., Wada, J.-I., Tanaka, T., et al. (1995) · PubMed · Cited by 24 · see citing works
Generation of Functional Hepatic Cells from Pluripotent Stem Cells
Han, S. (2012) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.s10-008 · Cited by 23 · cited 1× · see citing works
“There has been major headway in reconstituting enriched populations of hepatocyte-like cells from human PSCs (hPSCs) (Agarwal et al., 2008; Basma et al., 2009; Cai et al., 2007; Carpentier et al., 2014, 2016; Espejel et al., 2010; Han et al., 2012; Ogawa et al., 2013; Rashid et al., 2010; Si-Tayeb et al., 2010; Song e…”
BackgroundEvaluating the regenerative potential and functionality of human liver cells in mice
Tan, A. K. Y., Loh, K. M., & Ang, L. T. (2017) · Differentiation · doi:10.1016/j.diff.2017.09.003 · Cited by 12 · cited 1× · see citing works
“A coming challenge for developmental biology at-large will be to uncover the signal(s) that mature newly born differentiated cells in the embryo into fully fledged, functional cell types in neonates and adults (Tan et al., 2017), thus extending the reach of the present roadmap.”
BackgroundSelf-citationFoetal rise in hepatic enzymes follows decline in c-met and hepatocyte growth factor expression
Spijkers, J. A. A., van den Hoff, M. J. B., Hakvoort, T. B. M., et al. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00012-5 · Cited by 9 · cited 1× · see citing works
“, 2009) but diversify to form multiple functionally distinct hepatocyte subsets after birth (Colnot and Perret, 2011; Jungermann, 1995; Shiojiri et al., 1995; Spijkers et al., 2001), including periportal or pericentral hepatocytes that encircle, respectively, either portal or central veins (Smith and Campbell, 1988).”
Background
Flagged first, then by citations
Research works printed but not linked: 1
- Ledouarin, 1964, Induction of prehepatic endoderm by mesoderm of the cardiac region in the chick embryo, J. Embryol. Exp. Morphol., 12, 651
Cited by
Sorted by citations
Hofer, M., & Lutolf, M. P. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00279-y · Cited by 1,184 · see citing works
Human heart-forming organoids recapitulate early heart and foregut development
Drakhlis, L., Biswanath, S., Farr, C.-M., Lupanow, V., Teske, J., Ritzenhoff, K., Franke, A., Manstein, F., Bolesani, E., Kempf, H., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00815-9 · Cited by 452 · see citing works
Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells
Hogrebe, N. J., Augsornworawat, P., Maxwell, K. G., Velazco-Cruz, L., & Millman, J. R. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0430-6 · Cited by 373 · see citing works
Cano-Gamez, K., Soskic, B., Roumeliotis, T. I., So, E., Smyth, D. J., Baldrighi, M., Willé, D., Nakic, N., Esparza-Gordillo, J., Larminie, C. G. C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15543-y · Cited by 274 · see citing works
Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease
Ramli, M. N. B., Lim, Y. S., Koe, C. T., Demircioglu, D., Tng, W., Gonzales, K. A. U., Tan, C. P., Szczerbinska, I., Liang, H., Soe, E. L., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.06.010 · Cited by 278 · see citing works
OrganoID: A versatile deep learning platform for tracking and analysis of single-organoid dynamics
Matthews, J. M., Schuster, B., Kashaf, S. S., Liu, P., Ben-Yishay, R., Ishay-Ronen, D., Izumchenko, E., Shen, L., Weber, C. R., Bielski, M. C., et al. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010584 · Cited by 179 · see citing works
“However, these approaches may alter intrinsic cellular dynamics from original samples [18,19], limit measurements to endpoint assays, or cause cumulative toxicity through longer growth times and limited diffusion through the hydrogel PLOS COMPUTATIONAL BIOLOGY OrganoID: A deep learning platform for tracking and analys…”
BackgroundA shared transcriptional code orchestrates temporal patterning of the central nervous system
Sagner, A., Zhang, I., Watson, T., Lázaro, J., Melchionda, M., & Briscoe, J. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001450 · Cited by 128 · see citing works
Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation
Vandana, J. J., Manrique, C., Lacko, L. A., & Chen, S. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.04.011 · Cited by 132 · see citing works
Velazquez, J. J., LeGraw, R., Moghadam, F., Tan, Y., Kilbourne, J. A., Maggiore, J. C., Hislop, J., Liu, S., Cats, D., Lopes, S. M. C. D. S., et al. (2020) · Cell Systems · doi:10.1016/j.cels.2020.11.002 · Cited by 103 · see citing works
“Transcription factor-based fate programing has been explored before to direct cell state (Ang et al., 2018; Busskamp et al., 2014; Sugimura et al., 2017) in human induced pluripotent stem cell (hiPSC) derived mono-cell cultures.”
BackgroundMartin, R. M., Fowler, J. L., Cromer, M., Lesch, B., Ponce, E., Uchida, N., Nishimura, T., Porteus, M. H., & Loh, K. (2020) · Nature Communications · doi:10.1038/s41467-020-16455-7 · Cited by 100 · see citing works
Self-citationZhang, L., Ma, X.-J.-N., Fei, Y.-Y., Han, H., Xu, J., Cheng, L., & Li, X. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108004 · Cited by 93 · see citing works
Fetal liver hematopoiesis: from development to delivery
Lewis, K., Yoshimoto, M., & Takebe, T. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02189-w · Cited by 93 · see citing works
“Sequencing in the fetal liver has shown a large number of genes that are differentially regulated compared to their adult bone marrow counterparts, many of which are associated with altered cell cycle [47].”
BackgroundStem cells for treatment of liver fibrosis/cirrhosis: clinical progress and therapeutic potential
Liu, P., Mao, Y., Xie, Y., Wei, J., & Yao, J. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03041-5 · Cited by 82 · see citing works
“Hepatic maturation can be monitored by the selective up-and down-regulation of a plethora of genes, early hepatic maturation markers such as α-fetoprotein (AFP), ALB, alpha-1-antitrypsin (A1AT), and so on, final hepatic maturation markers CytochromeP450 enzymes, hepatic transporters, and all the hepatic enzymes for ur…”
BackgroundFowler, J. L., Ang, L. T., & Loh, K. M. (2019) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.368 · Cited by 81 · see citing works
“…site (WNT) to differentiate hPSCs toward primitive streakcontaining populations as a prelude to downstream endoderm or mesoderm formation (e.g., Ang et al., 2018; Bernardo et al., 2011; Chu et al., 2019; D'Amour et al., 2006; Gertow et al., 2013; Li et al., 2019; Loh et al., 2014; Loh et al.,…”
BackgroundSelf-citationShah, P. P., Keough, K. C., Gjoni, K., Santini, G. T., Abdill, R. J., Wickramasinghe, N. M., Dundes, C. E., Karnay, A. M., Chen, A. C., Salomon, R. E. A., et al. (2023) · Genome biology · doi:10.1186/s13059-023-02849-5 · Cited by 74 · see citing works
“The composition of CDM3 basal medium (Ang et al., 2018) is: 45% IMDM + GlutaMAX (Thermo Fisher, 31980-097) + 45% F12 + GlutaMAX (Thermo Fisher, 31765-092) + 10% KnockOut serum replacement (Thermo Fisher, 10828028) + 1 mg/mL polyvinyl alcohol (Sigma, P8136-250G) + 1% v/v chemically defined lipid…”
BackgroundMethodResultInfluentialSelf-citationMesenchymal stromal cells: promising treatment for liver cirrhosis
Yao, L., Hu, X., Dai, K., Yuan, M., Liu, P., Zhang, Q., & Jiang, Y. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03001-z · Cited by 71 · see citing works
“[58] indicated that iPSCderived HLCs exhibited different hepatocyte activities in vitro at day 18 of differentiation, possessed CYP3A4 enzymatic activity, experienced positive staining for periodic acid Schiff in addition to the liver-specific surface marker ASGR1, and expressed hepatocyte markers, including albumin,…”
BackgroundThe future of liver transplantation
Feng, S., Roll, G. R., Rouhani, F. J., & Fueyo, A. S. (2024) · Hepatology · doi:10.1097/hep.0000000000000873 · Cited by 67 · see citing works
“[129,130] Future challenges will include scalability, cell recovery following cryopreservation, cost, and the logistics of treating patients in a sufficiently timely manner.”
Environmental enrichment preserves a young DNA methylation landscape in the aged mouse hippocampus
Zocher, S., Overall, R. W., Lesche, M., Dahl, A., & Kempermann, G. (2021) · Nature Communications · doi:10.1038/s41467-021-23993-1 · Cited by 65 · see citing works
Hepatocyte organoids and cell transplantation: What the future holds
Peng, W. C., Kraaier, L. J., & Kluiver, T. A. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00579-x · Cited by 59 · see citing works
Chien, Y., Hsiao, Y., Chou, S., Lin, T.-Y., Yarmishyn, A. A., Lai, W., Lee, M., Lin, Y., Lin, T.-W., Hwang, D., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01717-x · Cited by 58 · see citing works
Goulart, E., de Caires-Junior, L. C., Telles-Silva, K. A., Araújo, B. H. S., Kobayashi, G. S., Musso, C. M., Assoni, A. F., Oliveira, D., Caldini, E. T. E. G., Gerstenhaber, J. A., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1367-x · Cited by 57 · see citing works
Towards Multi-Organoid Systems for Drug Screening Applications
Miranda, C. C., Fernandes, T. G., Diogo, M. M., & Cabral, J. M. S. (2018) · Bioengineering · doi:10.3390/bioengineering5030049 · Cited by 56 · see citing works
“Like most of the internal organs, the liver derives from the definitive endoderm, and through a stepwise approach, liver bud progenitors and HLC can be obtained in vitro from hPSCs [93].”
BackgroundFunctional identity of hypothalamic melanocortin neurons depends on Tbx3
Quarta, C., Fisette, A., Xu, Y., Colldén, G., Legutko, B., Tseng, Y.-T., Reim, A., Wierer, M., De Rosa, M. C., Klaus, V., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-018-0028-1 · Cited by 54 · see citing works
De novo DNA methylation controls neuronal maturation during adult hippocampal neurogenesis
Zocher, S., Overall, R. W., Berdugo‐Vega, G., Rund, N., Karasinsky, A., Adusumilli, V. S., Steinhauer, C., Scheibenstock, S., Händler, K., Schultze, J. L., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020107100 · Cited by 51 · see citing works
Graffmann, N., Scherer, B., & Adjaye, J. (2022) · Stem Cell Research · doi:10.1016/j.scr.2022.102763 · Cited by 54 · see citing works
Branco, M. A., Dias, T. P., Cabral, J. M. S., Pinto‐do‐Ó, P., & Diogo, M. M. (2022) · Nature Communications · doi:10.1038/s41467-022-34730-7 · Cited by 51 · see citing works
New Drug Discovery Paradigms for Retinal Diseases: A Focus on Retinal Organoids
Aasen, D. M., & Vergara, M. N. (2019) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2018.0140 · Cited by 49 · see citing works
Wruck, W., Bremmer, F., Kotthoff, M., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16222 · Cited by 50 · see citing works
Translating Embryogenesis to Generate Organoids: Novel Approaches to Personalized Medicine
Sahu, S., & Sharan, S. K. (2020) · iScience · doi:10.1016/j.isci.2020.101485 · Cited by 49 · see citing works
Roth, J. G., Muench, K. L., Asokan, A., Mallett, V. M., Gai, H., Verma, Y., Weber, S., Charlton, C. A., Fowler, J. L., Loh, K. M., et al. (2020) · eLife · doi:10.7554/elife.58178 · Cited by 47 · see citing works
“…to endoderm and mesoderm lineages hiPSC cells grow in mTeSR were dissociated into single cells using accutase and plated at density of 25–50 k cells/cm2 on matrigel coated cell culture plates and subsequently differentiated into endoderm and mesoderm lineages (Loh et al., 2014; Ang et al., 2018).”
MethodSelf-citationFetal liver development and implications for liver disease pathogenesis
Lotto, J., Stephan, T. L., & Hoodless, P. A. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00775-2 · Cited by 47 · see citing works
Pioneer and PRDM transcription factors coordinate bivalent epigenetic states to safeguard cell fate
Matsui, S., Granitto, M., Buckley, M., Ludwig, K., Koigi, S., Shiley, J. R., Zacharias, W. J., Mayhew, C. N., Lim, H., & Iwafuchi, M. (2024) · Molecular Cell · doi:10.1016/j.molcel.2023.12.007 · Cited by 46 · see citing works
Fowler, J. L., Zheng, S. L., Nguyen, A. T., Chen, A. C., Xiong, X., Chai, T., Chen, J. Y., Karigane, D., Banuelos, A. M., Niizuma, K., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.03.003 · Cited by 47 · see citing works
Self-citationA multi-tissue metabolome atlas of primate pregnancy
Yu, D., Wan, H., Tong, C., Guang, L., Chen, G., Su, J., Zhang, L., Wang, Y., Xiao, Z., Zhai, J., et al. (2024) · Cell · doi:10.1016/j.cell.2023.11.043 · Cited by 47 · see citing works
Dardano, M., Kleemiß, F., Kosanke, M., Lang, D., Wilson, L., Franke, A., Teske, J., Shivaraj, A., de la Roche, J., Fischer, M., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01526-4 · Cited by 45 · see citing works
“28,44 and no AFE was detectable, confirming the almost entire loss of endodermal tissue in BG-HFOs.”
Gröger, M., Matsuo, K., Arash, E. H., Pereira, A., Guillou, D. L., Pino, C., Telles-Silva, K. A., Maher, J. J., Hsiao, E. C., & Willenbring, H. (2023) · Nature Communications · doi:10.1038/s41467-023-39311-w · Cited by 44 · see citing works
Pettinato, G., Coughlan, M. F., Zhang, X., Chen, L., Khan, U., Glyavina, M., Sheil, C. J., Upputuri, P. K., Zakharov, Y. N., Vitkin, E. I., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj2800 · Cited by 44 · see citing works
Feng, S., Wu, J., Qiu, W., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2020.108455 · Cited by 43 · see citing works
Yang, D., Cho, H., Tayyebi, Z., Shukla, A., Luo, R., Dixon, G., Ursu, V., Stransky, S., Tremmel, D. M., Sackett, S. D., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00946-4 · Cited by 40 · see citing works
Molecular and genetic regulation of pig pancreatic islet cell development
Kim, S., Whitener, R. L., Peiris, H. S., Gu, X., Chang, C., Lam, J. Y., Camuñas-Soler, J., Park, I., Bevacqua, R. J., Tellez, K., et al. (2020) · Development · doi:10.1242/dev.186213 · Cited by 41 · see citing works
Shrestha, S., Lekkala, V. K. R., Acharya, P., Kang, S., Vanga, M. G., & Lee, M. (2024) · Lab on a Chip · doi:10.1039/d4lc00149d · Cited by 41 · see citing works
Suzuki, K., Koyanagi‐Aoi, M., Uehara, K., Hinata, N., Fujisawa, M., & Aoi, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-46848-8 · Cited by 38 · see citing works
Propagation of human prostate tissue from induced pluripotent stem cells
Hepburn, A. C., Curry, E. L., Moad, M., Steele, R. E., Franco, O. E., Wilson, L., Singh, P., Buskin, A., Crawford, S. E., Gaughan, L., et al. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0286 · Cited by 36 · see citing works
Aghadi, M., Elgendy, R., & Abdelalim, E. M. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05158-0 · Cited by 36 · see citing works
“Wild-type (WT) and FOXA2iPSCs were differentiated into hepatocytes using the previously published protocol [45] with slight modifications.”
MethodHuman Three-Dimensional Hepatic Models: Cell Type Variety and Corresponding Applications
Xu, Q. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.730008 · Cited by 36 · see citing works
“…natural development of the liver, when pluripotent epiblast cells sequentially turn into primitive streak, definitive endoderm, posterior foregut endoderm, embryonic liver progenitors, and hepatocytes under a series of stimulations (Ang et al., 2018; Ober and Lemaigre, 2018; Prior et al., 2019).”
BackgroundVarghese, D. S., Alawathugoda, T. T., & Ansari, S. A. (2019) · Stem Cells International · doi:10.1155/2019/5968236 · Cited by 32 · see citing works
“Therefore, further differentiation of DE into hepatic fate involves pathways which could induce hepatic fate and at the same time suppress other DE-derived cell fates [3].”
BackgroundElectromembrane Extraction and Mass Spectrometry for Liver Organoid Drug Metabolism Studies
Skottvoll, F. S., Hansen, F. A., Harrison, S. P., Boger, I. C. S., Mrsa, A., Restan, M. S., Stein, M., Lundanes, E., Pedersen‐Bjergaard, S., Aizenshtadt, A., et al. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c05082 · Cited by 32 · see citing works
A nuclear receptor facilitates differentiation of human PSCs into more mature hepatocytes
Ma, H., de Zwaan, E., Guo, Y. E., Cejas, P., Thiru, P., van de Bunt, M., Jeppesen, J. F., Syamala, S., Dall’Agnese, A., Abraham, B. J., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.03.015 · Cited by 35 · see citing works
Generation of Pancreatic Progenitors from Human Pluripotent Stem Cells by Small Molecules
Jiang, Y., Chen, C., Randolph, L. N., Ye, S., Zhang, X., Bao, X., & Lian, X. L. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.07.021 · Cited by 32 · see citing works
“We have developed PP and liver bud differentiation protocols based on previously described protocols (Ang et al., 2018; Nostro et al., 2015).”
Cotovio, J. P., & Fernandes, T. G. (2020) · Bioengineering · doi:10.3390/bioengineering7020036 · Cited by 30 · see citing works
“Trying to overcome this challenge, recent studies attempt to recapitulate hepatocyte development through a sequence of six consecutive lineage choices [40].”
BackgroundInfluentialAizenshtadt, A., Wang, C., Abadpour, S., Menezes, P. D., Wilhelmsen, I., Dalmao‐Fernández, A., Stokowiec, J., Golovin, A., Johnsen, M., Combriat, T. M. D., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303785 · Cited by 30 · see citing works
Inada, H., Udono, M., Matsuda‐Ito, K., Horisawa, K., Ohkawa, Y., Miura, S., Goya, T., Yamamoto, J., Nagasaki, M., Ueno, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19041-z · Cited by 30 · see citing works
Gheibi, S., Singh, T., da Cunha, J. P. D., Fex, M., & Mulder, H. (2020) · Cells · doi:10.3390/cells9112465 · Cited by 22 · see citing works
“Induces mesoderm lineage in adipocyte differentiation [78,186,187]”
Advances in generating liver cells from pluripotent stem cells as a tool for modeling liver diseases
Maepa, W., & Ndlovu, H. (2020) · Stem Cells · doi:10.1002/stem.3154 · Cited by 29 · see citing works
“bonemorphogenic factor 4 (BMP4), fibroblast growth factor 2 (FGF2), and vascular endothelial growth factor (VEGF).(1,7,10,18,19) The resulting DE cells express Sox17, FOXA2, CXCR4, and CERBELUS1.”
BackgroundMethodInfluentialThe Influence of Chronic Liver Diseases on Hepatic Vasculature: A Liver-on-a-chip Review
Özkan, A., Stolley, D. L., Cressman, E. N. K., McMillin, M., DeMorrow, S., Yankeelov, T. E., & Rylander, M. N. (2020) · Micromachines · doi:10.3390/mi11050487 · Cited by 26 · see citing works
“Pluripotent stem cells (iPSCs) differentiated to hepatocytes also showed stable albumin, urea, and CYP450 activity [46,47].”
BackgroundAguado-Fraile, E., Tassinari, A. M., Ishii, Y., Sigel, C., Lowery, M. A., Goyal, L., Gliser, C., Jiang, L., Pandya, S. S., Wu, B., et al. (2021) · Future Oncology · doi:10.2217/fon-2020-1274 · Cited by 28 · see citing works
Cryopreservation of organoids: Strategies, innovation, and future prospects
Han, H., Zhan, T., Guo, N., Cui, M., & Xu, Y. (2024) · Biotechnology Journal · doi:10.1002/biot.202300543 · Cited by 28 · see citing works
“[3] The diversity of organoids spans various organ types, such as intestinal liver, [4–8] pancreas, [9–13] gut, [14–17] stomach, [18–20] kidney, [21–23] mammary glands, [24,25] prostate, [26–29] and brain [30–36] (Figure 1).”
BackgroundHepatic Differentiation of Stem Cells in 2D and 3D Biomaterial Systems
Zhao, X., Zhu, Y., Laslett, A. L., & Chan, H. F. (2020) · Bioengineering · doi:10.3390/bioengineering7020047 · Cited by 28 · see citing works
Dynamic 3D genome reorganization during development and metabolic stress of the porcine liver
Chen, L., Li, J., Yuan, R., Wang, Y., Zhang, J., Lin, Y., Wang, L., Zhu, X., Zhu, W., Bai, J., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00416-z · Cited by 28 · see citing works
Direct reprogramming of somatic cells into induced hepatocytes: Cracking the Enigma code
Rombaut, M., Boeckmans, J., Rodrigues, R. M., van Grunsven, L. A., Vanhaecke, T., & Kock, J. D. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.04.048 · Cited by 26 · see citing works
Antarianto, R. D., Pragiwaksana, A., Septiana, W. L., Mazfufah, N. F., & Mahmood, A. (2022) · Organogenesis · doi:10.1080/15476278.2022.2061263 · Cited by 26 · see citing works
Transposable elements that have recently been mobile in the human genome
Autio, M. I., Amin, T. B., Perrin, A., Wong, J. Y., Foo, R., & Prabhakar, S. (2021) · BMC Genomics · doi:10.1186/s12864-021-08085-0 · Cited by 25 · see citing works
“Two pairs of gRNAs flanking the TE were annealed and ligated into pMIA3 1sgeSpCas9-2AmRuby2-2Amp53DD (Addgene plasmid #109399) [87].”
MethodSelf-citationKato, Y., Lim, A. Y., Sakolish, C., Valdiviezo, A., Moyer, H. L., Hewitt, P. G., Bajaj, P., Han, G., & Rusyn, I. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105464 · Cited by 27 · see citing works
Abbasalizadeh, S., Babaee, S., Kowsari‐Esfahan, R., Mazidi, Z., Shi, Y., Wainer, J. A., Cabral, J. M. S., Langer, R., Traverso, G., & Baharvand, H. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202210233 · Cited by 27 · see citing works
Pek, N. M. Q., Liu, K. J., Nichane, M., & Ang, L. T. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.09.016 · Cited by 25 · see citing works
Self-citationNakai, S., Shibata, I., Shitamichi, T., Yamaguchi, H., Takagi, N., Inoue, T., Nakagawa, T., Kiyokawa, J., Wakabayashi, S., Miyoshi, T., et al. (2019) · Biology Open · doi:10.1242/bio.042192 · Cited by 23 · see citing works
Ma, H.-M., Zhang, Q., Yang, X., Hu, Y., Zhang, J., Chen, L., Zhao, B., Yang, W., & Xu, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8168988 · Cited by 22 · see citing works
“HNF4A is a member of the ligand-dependent nuclear receptor superfamily [22], which can regulate organism development [23], intestinal development [24], and epithelialHindawi Oxidative Medicine and Cellular Longevity Volume 2022, Article ID 8168988, 17 pages https://doi.”
NAC1 modulates autoimmunity by suppressing regulatory T cell–mediated tolerance
Yang, J., Ren, Y., Kumar, A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo0183 · Cited by 23 · see citing works
Establishment of Humanized Mice for the Study of HBV
Lai, F., Wee, C. Y. Y., & Chen, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.638447 · Cited by 22 · see citing works
Self-citationAdvancements in MAFLD Modeling with Human Cell and Organoid Models
Wang, S.-X., Yan, J.-S., & Chan, Y.-S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911850 · Cited by 22 · see citing works
Signalling pathways and transcriptional regulators orchestrating liver development and cancer
Campbell, S. A., Stephan, T. L., Lotto, J., Cullum, R., Drissler, S., & Hoodless, P. A. (2021) · Development · doi:10.1242/dev.199814 · Cited by 22 · see citing works
Advances in liver and pancreas organoids: how far we have come and where we go next
Sljukic, A., Jenkinson, J. G., Niksic, A., Prior, N., & Huch, M. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01116-1 · Cited by 23 · see citing works
“However, co-differentiation generates high cell type diversity at the expense of tissue architecture 38,39,165,166 .”
Engineered Platforms for Maturing Pluripotent Stem Cell–Derived Liver Cells for Disease Modeling
Yuan, Y., Cotton, K., Samarasekera, D. N., & Khetani, S. R. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.01.013 · Cited by 22 · see citing works
“For example, BMP signaling is upregulated or downregulated depending on the stage in differentiation.(62) Serial CRISPR-Cas9 activation schemes could be designed to achieve this activation and inhibition in a time dependent manner.”
BackgroundRecent advances in deriving human endodermal tissues from pluripotent stem cells.
Kechele, D. O., & Wells, J. M. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.07.009 · Cited by 16 · see citing works
Fagg, W. S., Liu, N., Braunschweig, U., de Castro, K. L. P., Chen, X., Ditmars, F. S., Widen, S. G., Donohue, J. P., Módis, K., Russell, W. K., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac327 · Cited by 21 · see citing works
“5 EGFP WT, polyclonal QKI-KO (poly), 1-12 QKI-KO clone (1-12), 4-2 QKIKO clone (4-2), and 4-5 QKI-KO clone (4-5) cells probed with antibodies for Tubulin (magenta) and panQKI antibodies (green; result shown is representative of 3 biological replicates).”
BackgroundTGF-β/YB-1/Atg7 axis promotes the proliferation of hepatic progenitor cells and liver fibrogenesis
Guo, Y., Zhu, J., Xu, X., Shen, B., Shen, Z., Li, B., Li, F., Gu, T., Cai, X., Dong, H., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166290 · Cited by 20 · see citing works
Skowron, M. A., Kotthoff, M., Bremmer, F., Ruhnke, K., Parmaksiz, F., Richter, A., Küffer, S., Reuter‐Jessen, K., Pauls, S., Stefanski, A., et al. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00636-3 · Cited by 19 · see citing works
Akiyama, S., Saku, N., Miyata, S., Ite, K., Toyoda, M., Kimura, T., Kuroda, M., Nakazawa, A., Kasahara, M., Nonaka, H., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02776-5 · Cited by 18 · see citing works
“The application of developmental approaches to human pluripotent stem cells to generate hepatocytes or hepatocyte-like cells has brought a new dimension to hepatology [5], but hepatocyte-like cells derived from human pluripotent stem cells are functionally immature [6].”
Jalil, S., Keskinen, T., Juutila, J., Sartori-Maldonado, R., Euro, L., Suomalainen, A., Lapatto, R., Kuuluvainen, E., Hietakangas, V., Otonkoski, T., et al. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2024.03.004 · Cited by 17 · see citing works
Qin, Y., Li, J., Heng, Y., Wang, Z., Wu, D., Rahman, M., Hu, P., Plötz, T., Hopp, A. V., Kurniawan, N. A., et al. (2025) · BMC Biology · doi:10.1186/s12915-025-02411-8 · Cited by 16 · see citing works
“However, fluorescence dye-based approaches may disrupt the intrinsic cellular dynamics of the original samples [16, 17] or induce cumulative toxicity due to prolonged culture periods and restricted diffusion within the hydrogel matrix [18].”
Hidalgo-Álvarez, J., Salas-Lucia, F., Cruz, D. V., Fonseca, T. L., & Bianco, A. C. (2023) · JCI Insight · doi:10.1172/jci.insight.173780 · Cited by 15 · see citing works
“Subsequently, the increase in the mRNA levels of HNF4A , TBX3 , and CDX2 (21, 22) signaled the organization of the PFG (Figure 1B).”
Chen, S., Liu, S., Shi, S., Yin, H. H., Tang, Y., Zhang, J., Li, W., Liu, G., Qu, K., Ding, X., et al. (2024) · Molecular Biology and Evolution · doi:10.1093/molbev/msae003 · Cited by 15 · see citing works
Functional Stem Cell Sorting via Integrative Droplet Synchronization
Sun, G., Teng, Y., Zhao, Z., et al. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c01312 · Cited by 15 · see citing works
Krumm, J., Sekine, K., Samaras, P., Brazovskaja, A., Breunig, M., Yasui, R., Kleger, A., Taniguchi, H., Wilhelm, M., Treutlein, B., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110604 · Cited by 15 · see citing works
Liver organoids in domestic animals: an expected promise for metabolic studies
Baquerre, C., Montillet, G., & Pain, B. (2021) · Veterinary Research · doi:10.1186/s13567-021-00916-y · Cited by 14 · see citing works
“Organ-in-a-Column” Coupled On-line with Liquid Chromatography-Mass Spectrometry
Kogler, S., Aizenshtadt, A., Harrison, S. P., Skottvoll, F. S., Berg, H. E., Abadpour, S., Scholz, H., Sullivan, G. J., Thiede, B., Lundanes, E., et al. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04530 · Cited by 14 · see citing works
Pan, T., Wang, N., Zhang, J., Yang, F., Chen, Y., Zhuang, Y., Xu, Y., Ji, F., You, K., Lin, X.-H., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02831-1 · Cited by 14 · see citing works
Autio, M. I., Motakis, E., Perrin, A., Amin, T. B., Tiang, Z., Do, D. V., Wang, J., Tan, J. H. J., Ding, S. S. L., Tan, W. X., et al. (2024) · eLife · doi:10.7554/elife.79592 · Cited by 14 · see citing works
Self-citationStandard Protocols for Characterising Primary and In Vitro‐Generated Human Hepatocytes
Heydari, Z., Gramignoli, R., Piryaei, A., Zahmatkesh, E., Pooyan, P., Seydi, H., Nussler, A. K., Szkolnicka, D., Rashidi, H., Najimi, M., et al. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70390 · Cited by 13 · see citing works
Cholangiogenic potential of human deciduous pulp stem cell-converted hepatocyte-like cells
Yuniartha, R., Yamaza, T., Sonoda, S., Yoshimaru, K., Matsuura, T., Yamaza, H., Oda, Y., Ohga, S., & Taguchi, T. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02113-8 · Cited by 14 · see citing works
Bandi, S., Tchaikovskaya, T. L., & Gupta, S. K. (2019) · Differentiation · doi:10.1016/j.diff.2019.01.005 · Cited by 13 · see citing works
“addition of oncogenes, such as SV40 T antigen in transplantation studies [16, 17].”
BackgroundInfluentialLiver Buds and Liver Organoids: New Tools for Liver Development, Disease and Medical Application
Zeng, F., Zhang, Y., Han, X., Weng, J., & Gao, Y. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09909-z · Cited by 13 · see citing works
“can also be applied to cell-based therapy [65, 66] and liver organogenesis [67].”
BackgroundKumar, V., Pouw, R. B., Autio, M. I., Sagmeister, M. G., Phua, Z. Y., Borghini, L., Wright, V. J., Hoggart, C., Pan, B., Tan, A. K. Y., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.08.001 · Cited by 12 · see citing works
“Wild-type and CRISPR/Cas-targeted H1 human embryonic stem (hES) cells were differentiated to hepatocyte-like cells over 18 days as previously described.(34)”
MethodSelf-citationLee, C. J. M., Autio, M. I., Zheng, W., Song, Y., Wang, S. C., Wong, D. C. P., Xiao, J., Zhu, Y., Yusoff, P., Yei, X., et al. (2024) · Circulation · doi:10.1161/circulationaha.122.061335 · Cited by 12 · see citing works
Self-citationLoh, K. M., Zheng, S. L., Liu, K. J., Yin, Q., Amir-Ugokwe, Z. A., Jha, S. K., Qi, Y., Wazny, V. K., Nguyen, A. T., Chen, A. C., et al. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.103494 · Cited by 12 · see citing works
Self-citationPeaslee, C., Esteva‐Font, C., Su, T., Muñoz, A. S., Duwaerts, C. C., Liu, Z., Rao, S. A., Liu, K., Medina, M. W., Sneddon, J. B., et al. (2021) · Hepatology · doi:10.1002/hep.31898 · Cited by 12 · see citing works
“More important, the ML1 protocol allowed induction of complete monolayers of endoderm from nearly all iPSC lines tested, even those that failed other protocols recommended for poorly differentiating iPSCs.(15,17)”
Exploring Diverse Coagulation Factor XIII Subunit Expression Datasets: A Bioinformatic Analysis
Jamil, M. A., Singh, S., El‐Maarri, O., Oldenburg, J., & Biswas, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094725 · Cited by 12 · see citing works
“GSE98324: In the original study corresponding to this dataset, research groups at the National University of Singapore collected array data from 32 distinct human-derived samples [18].”
MethodFattahi, P., de Hoyos‐Vega, J. M., Choi, J. H., Duffy, C. D., Gonzalez‐Suarez, A. M., Ishida, Y., Nguyen, K. M., Gwon, K., Peterson, Q. P., Saito, T., et al. (2023) · Cells · doi:10.3390/cells12151982 · Cited by 12 · see citing works
Evaluating the regenerative potential and functionality of human liver cells in mice
Tan, A. K. Y., Loh, K. M., & Ang, L. T. (2017) · Differentiation · doi:10.1016/j.diff.2017.09.003 · Cited by 12 · see citing works
Self-citationMarx, U., Accastelli, E., David, R. M., Erfurth, H., Koenig, L., Lauster, R., Ramme, A. P., Reinke, P., Volk, H., Winter, A., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.728866 · Cited by 13 · see citing works
- Authors
- Ang, L. T., Tan, A. K. Y., Autio, M. I., Goh, S. H., Choo, S. H., Lee, K. L., Tan, J., Pan, B., Lee, J. J. H., Lum, J. J., Lim, C. Y. Y., Yeo, I. K. X., Wong, C. J. Y., Liu, M., Oh, J. L. L., Chia, C. P. L., Loh, C. H., Chen, A., Chen, Q., Weissman, I. L., Loh, K. M., & Lim, B.
- Affiliations
- Agency for Science, Technology and Research (SG)
- Duke-NUS Medical School (SG)
- Stanford Medicine (US)
- Corresponding author
- Ang, Lay Teng
- Lim, Bing
- ORCID
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 22
- Issue
- 8
- Pages
- 2190-2205
- ISSN
- 2211-1247 (ISSN-L)
- PMC
- PMC5854481
- OpenAlex
- W2788541418
- Cited by
- 220
- References
- 88
- Citations by year
- 2026: 15 · 2025: 27 · 2024: 34 · 2023: 19 · 2022: 39 · 2021: 35 · 2020: 30 · 2019: 19 · 2018: 1 · 2017: 1
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cell Reports (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (submittedVersion, cc-by-nc-nd)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- National University of Singapore (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DR-NTU (Nanyang Technological University) (submittedVersion, cc-by-nc-nd)
- Funders
- NIH Office of the Director (DP5OD024558)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- human pluripotent stem cells, liver differentiation, hepatocyte-like cells, extracellular signaling, retinoid signaling, Wnt signaling, TGF-beta signaling, TBX3, HNF4α
- MeSH terms
- Animals, Animals, Newborn, Biliary Tract, Cell Differentiation, Endoderm, Fibroblast Growth Factors, Humans, Liver, Tretinoin, Signal Transduction, Biomarkers, Cyclic AMP-Dependent Protein Kinases, Bone Morphogenetic Proteins, Hepatocytes, Pluripotent Stem Cells, Gastrointestinal Tract, Mice, High-Throughput Screening Assays, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-23.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-23.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review